A	O
Myc-associated	B-DNA
zinc	I-DNA
finger	I-DNA
protein	I-DNA
binding	I-DNA
site	I-DNA
is	O
one	O
of	O
four	O
important	O
functional	B-DNA
regions	I-DNA
in	O
the	O
CD4	B-DNA
promoter	I-DNA
.	O

The	O
CD4	B-DNA
promoter	I-DNA
plays	O
an	O
important	O
role	O
in	O
the	O
developmental	O
control	O
of	O
CD4	B-protein
transcription	O
.	O

In	O
this	O
report	O
,	O
we	O
show	O
that	O
the	O
minimal	O
CD4	B-DNA
promoter	I-DNA
has	O
four	O
factor	B-DNA
binding	I-DNA
sites	I-DNA
,	O
each	O
of	O
which	O
is	O
required	O
for	O
full	O
function	O
.	O

Using	O
biochemical	O
and	O
mutagenesis	O
analyses	O
,	O
we	O
determined	O
that	O
multiple	O
nuclear	B-protein
factors	I-protein
bind	O
to	O
these	O
independent	O
sites	O
.	O

We	O
determined	O
that	O
an	O
initiator-like	B-DNA
sequence	I-DNA
present	O
at	O
the	O
cap	B-DNA
site	I-DNA
and	O
an	O
Ets	B-DNA
consensus	I-DNA
sequence	I-DNA
are	O
required	O
for	O
full	O
promoter	B-DNA
function	O
.	O

We	O
also	O
demonstrate	O
that	O
the	O
Myc-associated	B-protein
zinc	I-protein
finger	I-protein
protein	I-protein
(	O
MAZ	B-protein
)	O
appears	O
to	O
be	O
the	O
predominant	B-protein
factor	I-protein
binding	O
to	O
one	O
of	O
these	O
sites	O
.	O

This	O
last	O
site	O
closely	O
resembles	O
the	O
ME1a1	B-DNA
G3AG4AG3	I-DNA
motif	I-DNA
previously	O
shown	O
to	O
be	O
a	O
critical	O
element	O
in	O
the	O
P2	B-DNA
promoter	I-DNA
of	O
the	O
c-myc	B-DNA
gene	I-DNA
.	O

We	O
therefore	O
believe	O
that	O
the	O
MAZ	B-protein
transcription	I-protein
factor	I-protein
is	O
also	O
likely	O
to	O
play	O
an	O
important	O
role	O
in	O
the	O
control	O
of	O
developmental	O
expression	O
of	O
the	O
CD4	B-DNA
gene	I-DNA
.	O

MoLECULAR	NULL
AND	NULL
CELLULAR	NULL
BroLOGY	NULL
,	NULL
June	NULL
1995	NULL
,	NULL
p.	NULL
3179-3186	NULL
0270-7306/95/	NULL
$	NULL
04.00+0	NULL
Copyright	NULL
Â©	NULL
1995	NULL
,	NULL
American	NULL
Society	NULL
for	NULL
Microbiology	NULL
Vol	NULL
.	NULL

15	NULL
,	NULL
No	NULL
.	NULL

6	NULL
A	NULL
Myc-Associated	NULL
Zinc	NULL
Finger	NULL
Protein	NULL
Binding	NULL
Site	NULL
Is	NULL
One	NULL
of	NULL
Four	NULL
Important	NULL
Functional	NULL
Regions	NULL
in	NULL
the	NULL
CD4	NULL
Promoter	NULL
DAVID	NULL
D.	NULL
DUNCAN	NULL
,	NULL
``	NULL
AMANDA	NULL
STUPAKOFEF	NULL
,	NULL
``	NULL
STEPHEN	NULL
M.	NULL
HEDRICK	NULL
,	NULL
``	NULL
KENNETH	NULL
B.	NULL
MARCU	NULL
,	NULL
``	NULL
anp	NULL
GERALD	NULL
SIU'*	NULL
Department	NULL
of	NULL
Microbiology	NULL
,	NULL
Columbia	NULL
University	NULL
,	NULL
College	NULL
of	NULL
Physicians	NULL
and	NULL
Surgeons	NULL
,	NULL
New	NULL
York	NULL
,	NULL
New	NULL
York	NULL
10032	NULL
;	NULL
Department	NULL
of	NULL
Biochemistry	NULL
and	NULL
Cell	NULL
Biology	NULL
,	NULL
State	NULL
University	NULL
of	NULL
New	NULL
York	NULL
at	NULL
Stony	NULL
Brook	NULL
,	NULL
Stony	NULL
Brook	NULL
,	NULL
New	NULL
York	NULL
11794	NULL
``	NULL
;	NULL
and	NULL
Department	NULL
of	NULL
Biology	NULL
and	NULL
Cancer	NULL
Center	NULL
,	NULL
University	NULL
of	NULL
California	NULL
,	NULL
San	NULL
Diego	NULL
,	NULL
La	NULL
Jolla	NULL
,	NULL
California	NULL
92093	NULL
``	NULL
Received	NULL
10	NULL
June	NULL
1994/Returned	NULL
for	NULL
modification	NULL
5	NULL
August	NULL
1994/Accepted	NULL
24	NULL
March	NULL
1995	NULL
The	NULL
CD4	NULL
promoter	NULL
plays	NULL
an	NULL
important	NULL
role	NULL
in	NULL
the	NULL
developmental	NULL
control	NULL
of	NULL
CD4	NULL
transcription	NULL
.	NULL

In	NULL
this	NULL
report	NULL
,	NULL
we	NULL
show	NULL
that	NULL
the	NULL
minimal	NULL
CD4	NULL
promoter	NULL
has	NULL
four	NULL
factor	NULL
binding	NULL
sites	NULL
,	NULL
each	NULL
of	NULL
which	NULL
is	NULL
required	NULL
for	NULL
full	NULL
function	NULL
.	NULL

Using	NULL
biochemical	NULL
and	NULL
mutagenesis	NULL
analyses	NULL
,	NULL
we	NULL
determined	NULL
that	NULL
multiple	NULL
nuclear	NULL
factors	NULL
bind	NULL
to	NULL
these	NULL
independent	NULL
sites	NULL
.	NULL

We	NULL
determined	NULL
that	NULL
an	NULL
initiator-like	NULL
sequence	NULL
present	NULL
at	NULL
the	NULL
cap	NULL
site	NULL
and	NULL
an	NULL
Ets	NULL
consensus	NULL
sequence	NULL
are	NULL
required	NULL
for	NULL
full	NULL
promoter	NULL
function	NULL
.	NULL

We	NULL
also	NULL
demonstrate	NULL
that	NULL
the	NULL
Myc-associated	NULL
zinc	NULL
finger	NULL
protein	NULL
(	NULL
MAZ	NULL
)	NULL
appears	NULL
to	NULL
be	NULL
the	NULL
predominant	NULL
factor	NULL
binding	NULL
to	NULL
one	NULL
of	NULL
these	NULL
sites	NULL
.	NULL

This	NULL
last	NULL
site	NULL
closely	NULL
resembles	NULL
the	NULL
MElal	NULL
G	NULL
,	NULL
AG	NULL
,	NULL
AG	NULL
,	NULL
motif	NULL
previously	NULL
shown	NULL
to	NULL
be	NULL
a	NULL
critical	NULL
element	NULL
in	NULL
the	NULL
P2	NULL
promoter	NULL
of	NULL
the	NULL
c-myc	NULL
gene	NULL
.	NULL

We	NULL
therefore	NULL
believe	NULL
that	NULL
the	NULL
MAZ	NULL
transcription	NULL
factor	NULL
is	NULL
also	NULL
likely	NULL
to	NULL
play	NULL
an	NULL
important	NULL
role	NULL
in	NULL
the	NULL
control	NULL
of	NULL
developmental	NULL
expression	NULL
of	NULL
the	NULL
CD4	NULL
gene	NULL
.	NULL

The	NULL
CD4	NULL
cell	NULL
surface	NULL
glycoprotein	NULL
is	NULL
an	NULL
important	NULL
molecule	NULL
in	NULL
T-cell	NULL
development	NULL
and	NULL
activation	NULL
(	NULL
21	NULL
,	NULL
26	NULL
,	NULL
38	NULL
)	NULL
.	NULL

T	NULL
cells	NULL
recognize	NULL
antigens	NULL
as	NULL
oligopeptides	NULL
bound	NULL
to	NULL
molecules	NULL
encoded	NULL
by	NULL
the	NULL
major	NULL
histocompatibility	NULL
complex	NULL
(	NULL
11	NULL
,	NULL
42	NULL
)	NULL
.	NULL

CD4	NULL
and	NULL
CD8	NULL
,	NULL
similar	NULL
accessory	NULL
molecules	NULL
,	NULL
bind	NULL
to	NULL
nonpolymorphic	NULL
regions	NULL
of	NULL
major	NULL
histocompatibility	NULL
complex	NULL
class	NULL
II	NULL
and	NULL
class	NULL
I	NULL
molecules	NULL
,	NULL
respectively	NULL
,	NULL
thus	NULL
contributing	NULL
to	NULL
the	NULL
avidity	NULL
of	NULL
interaction	NULL
between	NULL
T	NULL
cells	NULL
and	NULL
antigen-presenting	NULL
cells	NULL
(	NULL
38	NULL
)	NULL
.	NULL

In	NULL
addition	NULL
,	NULL
the	NULL
expression	NULL
of	NULL
CD4	NULL
and	NULL
CD8	NULL
in	NULL
mature	NULL
T	NULL
cells	NULL
correlates	NULL
to	NULL
T-cell	NULL
function	NULL
.	NULL

CD4*~	NULL
CD8~	NULL
T	NULL
cells	NULL
consist	NULL
of	NULL
primarily	NULL
helper	NULL
T	NULL
cells	NULL
,	NULL
which	NULL
regulate	NULL
the	NULL
immune	NULL
response	NULL
by	NULL
producing	NULL
cytokines	NULL
,	NULL
whereas	NULL
CD4~	NULL
CD8	NULL
*	NULL
T	NULL
cells	NULL
consist	NULL
of	NULL
cytotoxic	NULL
T	NULL
cells	NULL
,	NULL
which	NULL
kill	NULL
virus-infected	NULL
cells	NULL
and	NULL
tumor	NULL
cells	NULL
(	NULL
11	NULL
,	NULL
42	NULL
)	NULL
.	NULL

The	NULL
expression	NULL
of	NULL
CD4	NULL
or	NULL
CD8	NULL
is	NULL
coordinated	NULL
with	NULL
T-cell	NULL
antigen	NULL
receptor	NULL
major	NULL
histocompatibility	NULL
complex	NULL
class	NULL
specificity	NULL
during	NULL
T-cell	NULL
development	NULL
in	NULL
the	NULL
thymus	NULL
.	NULL

During	NULL
this	NULL
process	NULL
,	NULL
immature	NULL
T	NULL
cells	NULL
that	NULL
migrate	NULL
to	NULL
the	NULL
thymus	NULL
express	NULL
low	NULL
levels	NULL
of	NULL
surface	NULL
CD4	NULL
only	NULL
(	NULL
48	NULL
)	NULL
.	NULL

This	NULL
population	NULL
first	NULL
downregulates	NULL
CD4	NULL
expression	NULL
and	NULL
then	NULL
expresses	NULL
both	NULL
CD4	NULL
and	NULL
CD8	NULL
as	NULL
well	NULL
as	NULL
increasing	NULL
amounts	NULL
of	NULL
cell	NULL
surface	NULL
T-cell	NULL
antigen	NULL
receptor	NULL
(	NULL
10	NULL
)	NULL
.	NULL

This	NULL
CD4*	NULL
CD8*	NULL
(	NULL
double-posi-tive	NULL
)	NULL
population	NULL
then	NULL
undergoes	NULL
the	NULL
positive	NULL
and	NULL
negative	NULL
selection	NULL
processes	NULL
that	NULL
determine	NULL
both	NULL
antigen	NULL
and	NULL
major	NULL
histocompatibility	NULL
complex	NULL
specificity	NULL
and	NULL
also	NULL
loses	NULL
expression	NULL
of	NULL
either	NULL
CD4	NULL
or	NULL
CD8	NULL
;	NULL
only	NULL
those	NULL
T	NULL
cells	NULL
that	NULL
express	NULL
CD4	NULL
with	NULL
a	NULL
class	NULL
II-restricted	NULL
T-cell	NULL
antigen	NULL
receptor	NULL
or	NULL
CD8	NULL
with	NULL
a	NULL
class	NULL
TI-restricted	NULL
T-cell	NULL
antigen	NULL
receptor	NULL
survive	NULL
thymic	NULL
selection	NULL
(	NULL
24	NULL
,	NULL
43	NULL
)	NULL
.	NULL

Thus	NULL
,	NULL
the	NULL
expression	NULL
of	NULL
CD4	NULL
and	NULL
CD8	NULL
is	NULL
linked	NULL
with	NULL
the	NULL
developmental	NULL
program	NULL
of	NULL
developing	NULL
T	NULL
cells	NULL
as	NULL
they	NULL
mature	NULL
in	NULL
the	NULL
thymus	NULL
(	NULL
6	NULL
,	NULL
7	NULL
,	NULL
29	NULL
,	NULL
44	NULL
)	NULL
.	NULL

The	NULL
mechanism	NULL
by	NULL
which	NULL
expression	NULL
of	NULL
CD4	NULL
and	NULL
CD8	NULL
is	NULL
regulated	NULL
in	NULL
T-cell	NULL
development	NULL
and	NULL
linked	NULL
with	NULL
T-cell	NULL
function	NULL
remains	NULL
unclear	NULL
(	NULL
44	NULL
)	NULL
.	NULL

The	NULL
control	NULL
of	NULL
CD4	NULL
gene	NULL
expression	NULL
during	NULL
T-cell	NULL
activation	NULL
*	NULL
Corresponding	NULL
author	NULL
.	NULL

Mailing	NULL
address	NULL
:	NULL
HHSC	NULL
639	NULL
,	NULL
Department	NULL
of	NULL
Microbiology	NULL
,	NULL
Columbia	NULL
University	NULL
College	NULL
of	NULL
Physicians	NULL
and	NULL
Surgeons	NULL
,	NULL
701	NULL
West	NULL
168th	NULL
St.	NULL
,	NULL
New	NULL
York	NULL
,	NULL
NY	NULL
10032	NULL
.	NULL

Phone	NULL
:	NULL
(	NULL
212	NULL
)	NULL
305-2743	NULL
.	NULL

Fax	NULL
:	NULL
(	NULL
212	NULL
)	NULL
305-1468	NULL
.	NULL

Electronic	NULL
mail	NULL
address	NULL
:	NULL
siu	NULL
@	NULL
cusiu3.cce	NULL
.	NULL

columbia.edu	NULL
.	NULL

3179	NULL
and	NULL
development	NULL
has	NULL
been	NULL
a	NULL
topic	NULL
of	NULL
much	NULL
interest	NULL
recently	NULL
.	NULL

Nuclear	NULL
run-on	NULL
experiments	NULL
show	NULL
that	NULL
CD4	NULL
gene	NULL
expression	NULL
is	NULL
controlled	NULL
primarily	NULL
at	NULL
the	NULL
transcriptional	NULL
level	NULL
during	NULL
T-cell	NULL
development	NULL
and	NULL
activation	NULL
(	NULL
25	NULL
,	NULL
35	NULL
,	NULL
39	NULL
)	NULL
.	NULL

Using	NULL
both	NULL
transient	NULL
transfection	NULL
and	NULL
transgenic	NULL
approaches	NULL
,	NULL
we	NULL
and	NULL
others	NULL
have	NULL
identified	NULL
multiple	NULL
transcriptional	NULL
regulatory	NULL
elements	NULL
in	NULL
the	NULL
CD4	NULL
locus	NULL
(	NULL
4	NULL
,	NULL
13	NULL
,	NULL
14	NULL
,	NULL
19	NULL
,	NULL
30-33	NULL
,	NULL
35	NULL
,	NULL
36	NULL
)	NULL
.	NULL

These	NULL
regions	NULL
include	NULL
a	NULL
distal	NULL
enhancer	NULL
located	NULL
24	NULL
kb	NULL
5	NULL
'	NULL
of	NULL
the	NULL
first	NULL
CD4	NULL
exon	NULL
and	NULL
a	NULL
proximal	NULL
enhancer	NULL
located	NULL
13	NULL
kb	NULL
5	NULL
'	NULL
of	NULL
the	NULL
first	NULL
exon	NULL
(	NULL
31	NULL
,	NULL
32	NULL
,	NULL
49	NULL
)	NULL
;	NULL
both	NULL
of	NULL
these	NULL
enhancers	NULL
function	NULL
primarily	NULL
in	NULL
T	NULL
cells	NULL
.	NULL

We	NULL
and	NULL
others	NULL
have	NULL
identified	NULL
a	NULL
transcriptional	NULL
silencer	NULL
in	NULL
the	NULL
first	NULL
intron	NULL
;	NULL
this	NULL
silencer	NULL
element	NULL
is	NULL
required	NULL
for	NULL
full	NULL
tissue-	NULL
and	NULL
cell-type-specific	NULL
expression	NULL
of	NULL
CD4	NULL
(	NULL
33	NULL
,	NULL
35	NULL
)	NULL
.	NULL

In	NULL
addition	NULL
,	NULL
we	NULL
and	NULL
others	NULL
have	NULL
characterized	NULL
the	NULL
CD4	NULL
promoter	NULL
region	NULL
(	NULL
30	NULL
,	NULL
36	NULL
)	NULL
.	NULL

Using	NULL
transient	NULL
transfection	NULL
analysis	NULL
,	NULL
we	NULL
have	NULL
determined	NULL
that	NULL
the	NULL
murine	NULL
CD4	NULL
promoter	NULL
functions	NULL
at	NULL
high	NULL
levels	NULL
in	NULL
CD4*	NULL
CD8~	NULL
Ty	NULL
,	NULL
cells	NULL
and	NULL
at	NULL
lower	NULL
levels	NULL
in	NULL
CD4~	NULL
CD8	NULL
*	NULL
T	NULL
,	NULL
cells	NULL
(	NULL
36	NULL
)	NULL
.	NULL

In	NULL
order	NULL
to	NULL
understand	NULL
the	NULL
contribution	NULL
of	NULL
the	NULL
promoter	NULL
to	NULL
the	NULL
developmental	NULL
and	NULL
tissue-specific	NULL
regulation	NULL
of	NULL
CD4	NULL
expression	NULL
,	NULL
we	NULL
have	NULL
sought	NULL
to	NULL
define	NULL
all	NULL
the	NULL
essential	NULL
recognition	NULL
sequences	NULL
within	NULL
the	NULL
promoter	NULL
.	NULL

Using	NULL
deletion	NULL
analysis	NULL
,	NULL
we	NULL
determined	NULL
previously	NULL
that	NULL
101	NULL
bp	NULL
5	NULL
'	NULL
of	NULL
the	NULL
initiation	NULL
point	NULL
of	NULL
transcription	NULL
is	NULL
the	NULL
minimal	NULL
required	NULL
promoter	NULL
sequence	NULL
necessary	NULL
for	NULL
full	NULL
function	NULL
and	NULL
that	NULL
a	NULL
Myb	NULL
recognition	NULL
site	NULL
is	NULL
important	NULL
for	NULL
promoter	NULL
activity	NULL
.	NULL

In	NULL
this	NULL
study	NULL
,	NULL
using	NULL
linker-scanning	NULL
mutational	NULL
analyses	NULL
we	NULL
have	NULL
defined	NULL
four	NULL
regions	NULL
within	NULL
the	NULL
CD4	NULL
minimal	NULL
promoter	NULL
that	NULL
are	NULL
required	NULL
for	NULL
full	NULL
promoter	NULL
function	NULL
.	NULL

We	NULL
demonstrate	NULL
that	NULL
the	NULL
Myc-associated	NULL
zinc	NULL
finger	NULL
protein	NULL
(	NULL
MAZ	NULL
)	NULL
transcription	NULL
factor	NULL
(	NULL
5	NULL
,	NULL
18	NULL
,	NULL
28	NULL
)	NULL
binds	NULL
to	NULL
one	NULL
of	NULL
these	NULL
functionally	NULL
important	NULL
sites	NULL
in	NULL
the	NULL
CD4	NULL
promoter	NULL
and	NULL
therefore	NULL
is	NULL
likely	NULL
to	NULL
play	NULL
an	NULL
important	NULL
role	NULL
in	NULL
the	NULL
control	NULL
of	NULL
CD4	NULL
gene	NULL
expression	NULL
.	NULL

MATERIALS	NULL
AND	NULL
METHODS	NULL
Cell	NULL
transfection	NULL
and	NULL
maintenance	NULL
.	NULL

The	NULL
CD4*	NULL
CD8~	NULL
T-cell	NULL
clone	NULL
D10	NULL
and	NULL
the	NULL
CD4*	NULL
CD87	NULL
T-cell	NULL
lymphoma	NULL
Jurkat	NULL
were	NULL
maintained	NULL
and	NULL
transfected	NULL
as	NULL
described	NULL
previously	NULL
(	NULL
36	NULL
)	NULL
.	NULL

The	NULL
relative	NULL
activity	NULL
of	NULL
each	NULL
promoter	NULL
mutation	NULL
presented	NULL
in	NULL
Fig	NULL
.	NULL

1	NULL
reflects	NULL
normalization	NULL
to	NULL
a	NULL
control	NULL
transfection	NULL
of	NULL
a	NULL
construct	NULL
containing	NULL
the	NULL
luciferase	NULL
gene	NULL
under	NULL
the	NULL
transcriptional	NULL
control	NULL
of	NULL
the	NULL
human	NULL
3180	NULL
DUNCAN	NULL
ET	NULL
AL	NULL
.	NULL

A	NULL
-	NULL
-101	NULL
M	NULL
Myb	NULL
I	NULL
Myb	NULL
II	NULL
1	NULL
Mor	NULL
.	NULL

CELL	NULL
.	NULL

BioL	NULL
.	NULL

go	NULL
1	NULL
m	NULL
ti	NULL
h	NULL
w	NULL
bo	NULL
11	NULL
12	NULL
13	NULL
14	NULL
15	NULL
17	NULL
B	NULL
Functional	NULL
sites	NULL
1	NULL
Ito	NULL
two	NULL
fa	NULL
&	NULL
'=	NULL
100	NULL
'S	NULL
od	NULL
d	NULL
&	NULL
3	NULL
c	NULL
0	NULL
Mutation	NULL
B-actin	NULL
promoter	NULL
and	NULL
enhancer	NULL
,	NULL
which	NULL
functions	NULL
at	NULL
high	NULL
levels	NULL
in	NULL
this	NULL
cell	NULL
type	NULL
(	NULL
36	NULL
)	NULL
.	NULL

Average	NULL
light	NULL
unit	NULL
(	NULL
LU	NULL
)	NULL
values	NULL
obtained	NULL
with	NULL
the	NULL
D10	NULL
Ty	NULL
;	NULL
clone	NULL
were	NULL
20,000	NULL
LU	NULL
for	NULL
the	NULL
B-actin	NULL
construct	NULL
and	NULL
100	NULL
LU	NULL
for	NULL
a	NULL
promoterless	NULL
construct	NULL
.	NULL

Conditions	NULL
for	NULL
each	NULL
datum	NULL
point	NULL
were	NULL
internally	NULL
controlled	NULL
for	NULL
transfection	NULL
efficiency	NULL
by	NULL
cotransfecting	NULL
a	NULL
construct	NULL
containing	NULL
the	NULL
chloramphenicol	NULL
acetyltransferase	NULL
gene	NULL
under	NULL
the	NULL
control	NULL
of	NULL
the	NULL
thymidine	NULL
kinase	NULL
promoter	NULL
.	NULL

Generation	NULL
of	NULL
promoter	NULL
mutations	NULL
.	NULL

An	NULL
Msel-Xhol	NULL
restriction	NULL
enzyme	NULL
fragment	NULL
that	NULL
contained	NULL
the	NULL
minimal	NULL
CD4	NULL
promoter	NULL
between	NULL
positions	NULL
-101	NULL
and	NULL
+71	NULL
was	NULL
mutated	NULL
by	NULL
oligonucleotide-directed	NULL
mutagenesis	NULL
as	NULL
described	NULL
earlier	NULL
(	NULL
20	NULL
,	NULL
36	NULL
)	NULL
.	NULL

Each	NULL
oligonucleotide	NULL
was	NULL
designed	NULL
to	NULL
alter	NULL
a	NULL
specific	NULL
3-	NULL
to	NULL
6-bp	NULL
sequence	NULL
within	NULL
the	NULL
promoter	NULL
region	NULL
;	NULL
all	NULL
other	NULL
sequences	NULL
within	NULL
the	NULL
region	NULL
were	NULL
unaltered	NULL
,	NULL
as	NULL
determined	NULL
by	NULL
DNA	NULL
sequencing	NULL
.	NULL

The	NULL
mutated	NULL
promoter	NULL
fragments	NULL
were	NULL
cloned	NULL
into	NULL
the	NULL
pSVOALAS5	NULL
'	NULL
luciferase	NULL
reporter	NULL
vector	NULL
(	NULL
8	NULL
)	NULL
and	NULL
transfected	NULL
into	NULL
the	NULL
D10	NULL
CD4*	NULL
CD87	NULL
T	NULL
;	NULL
;	NULL
clone	NULL
in	NULL
order	NULL
to	NULL
determine	NULL
the	NULL
effects	NULL
of	NULL
the	NULL
mutations	NULL
on	NULL
promoter	NULL
function	NULL
.	NULL

DNase	NULL
footprinting	NULL
analysis	NULL
.	NULL

Nuclear	NULL
extracts	NULL
were	NULL
purified	NULL
from	NULL
mouse	NULL
T-cell	NULL
line	NULL
D10	NULL
and	NULL
human	NULL
leukemic	NULL
T-cell	NULL
lines	NULL
CCRF-CEM	NULL
and	NULL
Jurkat	NULL
as	NULL
described	NULL
earlier	NULL
(	NULL
36	NULL
,	NULL
46	NULL
)	NULL
.	NULL

DNase	NULL
I	NULL
footprinting	NULL
was	NULL
performed	NULL
essentially	NULL
as	NULL
described	NULL
earlier	NULL
(	NULL
16	NULL
)	NULL
.	NULL

A	NULL
mixture	NULL
of	NULL
end-labelled	NULL
promoter	NULL
fragment	NULL
(	NULL
positions	NULL
-101	NULL
to	NULL
+71	NULL
)	NULL
,	NULL
1	NULL
ug	NULL
of	NULL
poly	NULL
(	NULL
dI-dC	NULL
)	NULL
,	NULL
and	NULL
10	NULL
pl	NULL
of	NULL
10	NULL
%	NULL
polyvinyl	NULL
alcohol	NULL
was	NULL
incubated	NULL
with	NULL
40	NULL
pg	NULL
of	NULL
the	NULL
T-cell	NULL
nuclear	NULL
extracts	NULL
for	NULL
15	NULL
min	NULL
.	NULL

A	NULL
50-p.l	NULL
volume	NULL
of	NULL
10	NULL
mM	NULL
MgCl	NULL
;	NULL
and	NULL
5	NULL
mM	NULL
CaCl	NULL
,	NULL
was	NULL
added	NULL
before	NULL
the	NULL
addition	NULL
of	NULL
DNase	NULL
I	NULL
after	NULL
1	NULL
min	NULL
more	NULL
.	NULL

The	NULL
reaction	NULL
was	NULL
stopped	NULL
by	NULL
adding	NULL
90	NULL
pl	NULL
of	NULL
20	NULL
mM	NULL
EDTA-1	NULL
%	NULL
sodium	NULL
dodecyl	NULL
sulfate	NULL
(	NULL
SDS	NULL
)	NULL
-0.2	NULL
M	NULL
NaCl-325	NULL
pg	NULL
of	NULL
carrier	NULL
RNA	NULL
per	NULL
ml	NULL
,	NULL
and	NULL
the	NULL
product	NULL
was	NULL
then	NULL
phenol-chloroform	NULL
extracted	NULL
,	NULL
ethanol	NULL
precipitated	NULL
,	NULL
and	NULL
analyzed	NULL
on	NULL
a	NULL
sequencing	NULL
gel	NULL
.	NULL

EMSAs	NULL
.	NULL

Each	NULL
of	NULL
the	NULL
four	NULL
functionally	NULL
defined	NULL
regions	NULL
was	NULL
subcloned	NULL
into	NULL
the	NULL
plasmid	NULL
vector	NULL
pKS	NULL
(	NULL
Stratagene	NULL
Cloning	NULL
Systems	NULL
,	NULL
La	NULL
Jolla	NULL
,	NULL
Calif.	NULL
)	NULL
:	NULL
site	NULL
1	NULL
,	NULL
consisting	NULL
of	NULL
the	NULL
sequence	NULL
from	NULL
-101	NULL
to	NULL
-78	NULL
relative	NULL
to	NULL
the	NULL
cap	NULL
site	NULL
of	NULL
the	NULL
promoter	NULL
region	NULL
;	NULL
site	NULL
2	NULL
,	NULL
from	NULL
-78	NULL
to	NULL
-54	NULL
;	NULL
site	NULL
3	NULL
,	NULL
from	NULL
-55	NULL
to	NULL
-31	NULL
;	NULL
and	NULL
site	NULL
4	NULL
,	NULL
from	NULL
-20	NULL
to	NULL
+4	NULL
.	NULL

Probes	NULL
were	NULL
generated	NULL
from	NULL
these	NULL
subclones	NULL
,	NULL
labelled	NULL
,	NULL
and	NULL
incubated	NULL
at	NULL
room	NULL
temperature	NULL
with	NULL
nuclear	NULL
extracts	NULL
plus	NULL
1	NULL
jg	NULL
of	NULL
poly	NULL
(	NULL
dI-dC	NULL
)	NULL
(	NULL
Pharmacia	NULL
Biotech	NULL
,	NULL
Inc.	NULL
,	NULL
Piscataway	NULL
,	NULL
N.J.	NULL
)	NULL
in	NULL
a	NULL
solution	NULL
of	NULL
10	NULL
mM	NULL
HEPES	NULL
(	NULL
N-2-hydroxy-ethylpiperazine-N	NULL
'	NULL
-2-ethanesulfonic	NULL
acid	NULL
)	NULL
KOH	NULL
(	NULL
pH	NULL
7.9	NULL
)	NULL
,	NULL
50	NULL
mM	NULL
NaCl	NULL
,	NULL
5	NULL
mM	NULL
Tris-HCl	NULL
(	NULL
pH	NULL
7.5	NULL
)	NULL
,	NULL
25	NULL
mM	NULL
EDTA	NULL
,	NULL
1	NULL
mM	NULL
dithiothreitol	NULL
,	NULL
and	NULL
10	NULL
%	NULL
glycerol	NULL
.	NULL

After	NULL
20	NULL
min	NULL
,	NULL
the	NULL
reaction	NULL
mixtures	NULL
were	NULL
loaded	NULL
onto	NULL
a	NULL
4	NULL
%	NULL
nondenaturing	NULL
polyacry	NULL
]	NULL
-	NULL
FIG	NULL
.	NULL

1	NULL
.	NULL

Scanning	NULL
mutations	NULL
of	NULL
the	NULL
CD4	NULL
minimal	NULL
promoter	NULL
region	NULL
.	NULL

(	NULL
A	NULL
)	NULL
Sequence	NULL
of	NULL
the	NULL
CD4	NULL
promoter	NULL
between	NULL
-101	NULL
and	NULL
+14	NULL
.	NULL

The	NULL
inserted	NULL
nucleotide	NULL
changes	NULL
in	NULL
cach	NULL
mutated	NULL
promoter	NULL
fragment	NULL
are	NULL
indicated	NULL
;	NULL
a	NULL
solid	NULL
line	NULL
indicates	NULL
homology	NULL
with	NULL
the	NULL
unmutated	NULL
promoter	NULL
(	NULL
top	NULL
sequence	NULL
)	NULL
.	NULL

The	NULL
boxed	NULL
regions	NULL
indicate	NULL
the	NULL
cap	NULL
sites	NULL
.	NULL

Myb	NULL
I	NULL
and	NULL
Myb	NULL
II	NULL
are	NULL
mutations	NULL
disrupting	NULL
the	NULL
two	NULL
Myb	NULL
binding	NULL
sites	NULL
(	NULL
36	NULL
)	NULL
.	NULL

(	NULL
B	NULL
)	NULL
Functional	NULL
activity	NULL
of	NULL
the	NULL
CD4	NULL
promoter	NULL
mutations	NULL
in	NULL
CD4*	NULL
CD8~	NULL
T-cell	NULL
clone	NULL
D10	NULL
.	NULL

The	NULL
minimal	NULL
CD4	NULL
promoter	NULL
functions	NULL
at	NULL
high	NULL
levels	NULL
in	NULL
this	NULL
cell	NULL
type	NULL
;	NULL
mutated	NULL
promoter	NULL
activity	NULL
is	NULL
expressed	NULL
relative	NULL
to	NULL
that	NULL
of	NULL
the	NULL
unmutated	NULL
promoter	NULL
and	NULL
is	NULL
the	NULL
average	NULL
(	NULL
+2	NULL
standard	NULL
deviations	NULL
)	NULL
of	NULL
three	NULL
to	NULL
nine	NULL
independent	NULL
transfections	NULL
.	NULL

The	NULL
efficiency	NULL
of	NULL
each	NULL
transfection	NULL
was	NULL
determined	NULL
by	NULL
cotransfecting	NULL
the	NULL
chloramphenicol	NULL
acetyltransferase	NULL
gene	NULL
under	NULL
the	NULL
control	NULL
of	NULL
the	NULL
thymidine	NULL
kinase	NULL
promoter	NULL
.	NULL

Average	NULL
LU	NULL
values	NULL
obtained	NULL
with	NULL
the	NULL
D10	NULL
cell	NULL
line	NULL
were	NULL
20,000	NULL
LU	NULL
for	NULL
a	NULL
B-actin	NULL
construct	NULL
and	NULL
100	NULL
LU	NULL
for	NULL
a	NULL
promoterless	NULL
construct	NULL
.	NULL

The	NULL
functional	NULL
sites	NULL
are	NULL
indicated	NULL
as	NULL
numbered	NULL
solid	NULL
lines	NULL
.	NULL

amide	NULL
gel	NULL
and	NULL
run	NULL
at	NULL
22Â°C	NULL
in	NULL
glycine	NULL
buffer	NULL
(	NULL
190	NULL
mM	NULL
glycine	NULL
,	NULL
25	NULL
mM	NULL
Tris-HCl	NULL
[	NULL
pH	NULL
8.5	NULL
]	NULL
,	NULL
1	NULL
mM	NULL
EDTA	NULL
)	NULL
.	NULL

For	NULL
electrophoretic	NULL
mobility	NULL
shift	NULL
assays	NULL
(	NULL
EMSAs	NULL
)	NULL
,	NULL
1	NULL
to	NULL
2	NULL
pg	NULL
of	NULL
nuclear	NULL
extract	NULL
from	NULL
the	NULL
D10	NULL
or	NULL
Jurkat	NULL
T-cell	NULL
line	NULL
or	NULL
of	NULL
a	NULL
bacterial	NULL
lysate	NULL
containing	NULL
the	NULL
MAZ-MBP	NULL
fusion	NULL
protein	NULL
(	NULL
5	NULL
)	NULL
was	NULL
incubated	NULL
with	NULL
1.5	NULL
X	NULL
10*	NULL
cpm	NULL
of	NULL
the	NULL
labelled	NULL
probe	NULL
.	NULL

The	NULL
monoclonal	NULL
antibody	NULL
treatment	NULL
of	NULL
the	NULL
site	NULL
2	NULL
EMSA	NULL
was	NULL
carried	NULL
out	NULL
with	NULL
monoclonal	NULL
mouse	NULL
anti-MAZ	NULL
antibody	NULL
80	NULL
,	NULL
the	NULL
generation	NULL
and	NULL
characterization	NULL
of	NULL
which	NULL
will	NULL
be	NULL
described	NULL
elsewhere	NULL
(	NULL
37	NULL
)	NULL
.	NULL

The	NULL
reaction	NULL
procedure	NULL
consisted	NULL
of	NULL
a	NULL
30-min	NULL
preincubation	NULL
at	NULL
room	NULL
temperature	NULL
of	NULL
2	NULL
ug	NULL
of	NULL
D10	NULL
nuclear	NULL
extract	NULL
,	NULL
1	NULL
mg	NULL
of	NULL
poly	NULL
(	NULL
dI-dC	NULL
)	NULL
,	NULL
and	NULL
10	NULL
pl	NULL
of	NULL
antibody	NULL
in	NULL
reaction	NULL
buffer	NULL
followed	NULL
by	NULL
a	NULL
15-min	NULL
incubation	NULL
with	NULL
labelled	NULL
site	NULL
2	NULL
probe	NULL
.	NULL

Reaction	NULL
mixtures	NULL
were	NULL
loaded	NULL
onto	NULL
a	NULL
4	NULL
%	NULL
nondenaturing	NULL
polyacrylamide	NULL
gel	NULL
and	NULL
run	NULL
at	NULL
4Â°C	NULL
in	NULL
glycine	NULL
buffer	NULL
.	NULL

Southwestern	NULL
blot	NULL
analyses	NULL
.	NULL

Twenty	NULL
micrograms	NULL
of	NULL
Jurkat	NULL
nuclear	NULL
extract	NULL
was	NULL
resolved	NULL
on	NULL
an	NULL
SDS-10	NULL
%	NULL
polyacrylamide	NULL
gel	NULL
and	NULL
transferred	NULL
onto	NULL
a	NULL
nitrocellulose	NULL
membrane	NULL
.	NULL

Southwestern	NULL
(	NULL
DNA-protein	NULL
)	NULL
analyses	NULL
were	NULL
performed	NULL
as	NULL
described	NULL
previously	NULL
(	NULL
28	NULL
)	NULL
.	NULL

Blotted	NULL
proteins	NULL
were	NULL
denatured	NULL
by	NULL
incubation	NULL
at	NULL
4Â°C	NULL
for	NULL
5	NULL
min	NULL
in	NULL
binding	NULL
buffer	NULL
(	NULL
20	NULL
mM	NULL
HEPES	NULL
[	NULL
pH	NULL
7.9	NULL
]	NULL
,	NULL
3	NULL
mM	NULL
MgCl	NULL
,	NULL
,	NULL
40	NULL
mM	NULL
KCI	NULL
,	NULL
1	NULL
mM	NULL
dithiothreitol	NULL
)	NULL
containing	NULL
6	NULL
M.	NULL
guanidine	NULL
hydrochloride	NULL
.	NULL

This	NULL
solution	NULL
was	NULL
serially	NULL
diluted	NULL
with	NULL
equal	NULL
volumes	NULL
of	NULL
binding	NULL
buffer	NULL
in	NULL
a	NULL
series	NULL
of	NULL
four	NULL
5-min	NULL
incubations	NULL
to	NULL
renature	NULL
the	NULL
blotted	NULL
proteins	NULL
.	NULL

The	NULL
filters	NULL
were	NULL
prehybridized	NULL
in	NULL
binding	NULL
buffer-5	NULL
%	NULL
Carnation	NULL
nonfat	NULL
dry	NULL
milk	NULL
for	NULL
30	NULL
min	NULL
before	NULL
overnight	NULL
hy-bridization	NULL
at	NULL
4Â°C	NULL
in	NULL
binding	NULL
buffer-0.25	NULL
%	NULL
dry	NULL
milk	NULL
with	NULL
10Â°	NULL
cpm	NULL
of	NULL
site	NULL
2	NULL
probe	NULL
,	NULL
mutated	NULL
site	NULL
2	NULL
oligonucleotide	NULL
,	NULL
or	NULL
a	NULL
probe	NULL
consisting	NULL
of	NULL
the	NULL
Xbel-Xhol	NULL
fragment	NULL
of	NULL
the	NULL
pKS	NULL
multiple	NULL
cloning	NULL
site	NULL
per	NULL
ml	NULL
.	NULL

The	NULL
filters	NULL
were	NULL
washed	NULL
in	NULL
0.25	NULL
%	NULL
Carnation	NULL
nonfat	NULL
dry	NULL
milk	NULL
in	NULL
binding	NULL
buffer	NULL
at	NULL
4Â°C	NULL
and	NULL
exposed	NULL
to	NULL
X-ray	NULL
film	NULL
.	NULL

Approximate	NULL
molecular	NULL
weights	NULL
were	NULL
determined	NULL
with	NULL
prestained	NULL
standards	NULL
(	NULL
Bio-Rad	NULL
Laboratories	NULL
,	NULL
Hercules	NULL
,	NULL
Calif.	NULL
)	NULL
.	NULL

RESULTS	NULL
Four	NULL
functional	NULL
regions	NULL
within	NULL
the	NULL
CD4	NULL
promoter	NULL
bind	NULL
T-cell	NULL
nuclear	NULL
factors	NULL
.	NULL

Using	NULL
deletional	NULL
analysis	NULL
,	NULL
we	NULL
have	NULL
determined	NULL
that	NULL
101	NULL
bp	NULL
of	NULL
the	NULL
CD4	NULL
promoter	NULL
is	NULL
sufficient	NULL
to	NULL
generate	NULL
high	NULL
levels	NULL
of	NULL
promoter	NULL
activity	NULL
upon	NULL
transient	NULL
transfection	NULL
Vou	NULL
.	NULL

15	NULL
,	NULL
1995	NULL
-78	NULL
MAZ	NULL
-54	NULL
lonal	NULL
si	NULL
eTecccorcpercecheccactcer	NULL
Functional	NULL
site	NULL
#	NULL
2	NULL
GTTGACCCCCACCCTGAGGACT	NULL
-78	NULL
-54	NULL
fomal	NULL
a	NULL
Functional	NULL
site	NULL
#	NULL
2	NULL
mutant	NULL
GTTGACCCCCAC	NULL
CCCTeaAceact	NULL
CTGAGGGCTGGCTTACGTCCGCCGT	NULL
Functional	NULL
site	NULL
#	NULL
3	NULL
-20	NULL
ETS	NULL
+4	NULL
CTGACGACCAGGCTTCCTETCITTT	NULL
GACTGCTGGICCGAAGCACACRAAA	NULL
FIG	NULL
.	NULL

2	NULL
.	NULL

CD4	NULL
promoter	NULL
functional	NULL
sites	NULL
.	NULL

Nucleotide	NULL
sequences	NULL
of	NULL
the	NULL
func-	NULL
tional-site	NULL
oligonucleotides	NULL
used	NULL
in	NULL
the	NULL
EMSA	NULL
experiments	NULL
.	NULL

Homologies	NULL
to	NULL
known	NULL
factor	NULL
recognition	NULL
sequences	NULL
in	NULL
site	NULL
2	NULL
and	NULL
site	NULL
4	NULL
(	NULL
boxed	NULL
regions	NULL
)	NULL
and	NULL
bases	NULL
changed	NULL
in	NULL
the	NULL
site	NULL
2	NULL
mutant	NULL
(	NULL
boldface	NULL
letters	NULL
)	NULL
are	NULL
indicated	NULL
.	NULL

Functional	NULL
site	NULL
#	NULL
4	NULL
into	NULL
activated	NULL
CD4*	NULL
CD8~	NULL
T	NULL
cells	NULL
.	NULL

In	NULL
order	NULL
to	NULL
identify	NULL
the	NULL
cis-acting	NULL
sequences	NULL
within	NULL
this	NULL
region	NULL
that	NULL
are	NULL
required	NULL
for	NULL
promoter	NULL
function	NULL
,	NULL
we	NULL
generated	NULL
a	NULL
panel	NULL
of	NULL
mutations	NULL
that	NULL
span	NULL
the	NULL
complete	NULL
minimal	NULL
promoter	NULL
region	NULL
by	NULL
oligonucleotide-directed	NULL
mutagenesis	NULL
(	NULL
Fig	NULL
.	NULL

1A	NULL
)	NULL
.	NULL

Each	NULL
promoter	NULL
mutation	NULL
was	NULL
cloned	NULL
into	NULL
the	NULL
pSVOALAS	NULL
'	NULL
luciferase	NULL
reporter	NULL
vector	NULL
and	NULL
transfected	NULL
into	NULL
the	NULL
CD4*	NULL
CD8~	NULL
T-cell	NULL
clone	NULL
as	NULL
described	NULL
above	NULL
.	NULL

The	NULL
results	NULL
depicted	NULL
in	NULL
Fig	NULL
.	NULL

1B	NULL
represent	NULL
the	NULL
activity	NULL
of	NULL
each	NULL
construct	NULL
relative	NULL
to	NULL
that	NULL
of	NULL
the	NULL
unmutated	NULL
minimal	NULL
promoter	NULL
,	NULL
which	NULL
functions	NULL
at	NULL
high	NULL
levels	NULL
in	NULL
this	NULL
cell	NULL
type	NULL
(	NULL
36	NULL
)	NULL
.	NULL

Mutations	NULL
in	NULL
any	NULL
of	NULL
four	NULL
regions	NULL
reduced	NULL
promoter	NULL
activity	NULL
by	NULL
more	NULL
than	NULL
60	NULL
%	NULL
.	NULL

We	NULL
previously	NULL
demonstrated	NULL
that	NULL
a	NULL
Myb	NULL
family	NULL
member	NULL
binds	NULL
to	NULL
site	NULL
1	NULL
(	NULL
36	NULL
)	NULL
;	NULL
sequence	NULL
analysis	NULL
revealed	NULL
homology	NULL
of	NULL
site	NULL
2	NULL
to	NULL
the	NULL
ME1al1	NULL
site	NULL
of	NULL
the	NULL
Myc	NULL
promoter	NULL
(	NULL
2	NULL
)	NULL
and	NULL
an	NULL
Ets	NULL
family	NULL
consensus	NULL
sequence	NULL
within	NULL
site	NULL
4	NULL
(	NULL
30	NULL
)	NULL
.	NULL

A	NULL
A	NULL
.	NULL
)	NULL

B	NULL
.	NULL
)	NULL

Extract	NULL
-o	NULL
t	NULL
to	NULL
+o+	NULL
Extract	NULL
Competitor	NULL
_	NULL
-	NULL
S2	NULL
$	NULL
2	NULL
pKs	NULL
-	NULL
Competitor	NULL
Fold	NULL
excess	NULL
_	NULL
-	NULL
300	NULL
150	NULL
300	NULL
-	NULL
Fold	NULL
excess	NULL
--	NULL
>	NULL
hous	NULL
ag	NULL
aud	NULL
tne	NULL
das	NULL
can	NULL
A	NULL
MAZ	NULL
BINDING	NULL
SITE	NULL
IN	NULL
THE	NULL
CD4	NULL
PROMOTER	NULL
3181	NULL
search	NULL
of	NULL
the	NULL
National	NULL
Center	NULL
for	NULL
Biotechnology	NULL
Information	NULL
transcription	NULL
factor	NULL
database	NULL
revealed	NULL
that	NULL
site	NULL
3	NULL
is	NULL
similar	NULL
in	NULL
sequence	NULL
to	NULL
an	NULL
NFI/CTF	NULL
recognition	NULL
site	NULL
(	NULL
12	NULL
)	NULL
.	NULL

Oligonucleotides	NULL
encompassing	NULL
each	NULL
of	NULL
the	NULL
four	NULL
sites	NULL
were	NULL
used	NULL
as	NULL
radioactive	NULL
probes	NULL
in	NULL
EMSAs	NULL
with	NULL
nuclear	NULL
extracts	NULL
isolated	NULL
from	NULL
the	NULL
D10	NULL
CD4*	NULL
CD8~	NULL
T	NULL
,	NULL
,	NULL
clone	NULL
(	NULL
Fig	NULL
.	NULL

2	NULL
and	NULL
3	NULL
)	NULL
.	NULL

A	NULL
single	NULL
complex	NULL
was	NULL
observed	NULL
with	NULL
each	NULL
probe	NULL
(	NULL
Fig	NULL
.	NULL

3	NULL
)	NULL
,	NULL
indicating	NULL
that	NULL
the	NULL
functional	NULL
sites	NULL
define	NULL
factor	NULL
binding	NULL
sites	NULL
.	NULL

Each	NULL
of	NULL
the	NULL
complexes	NULL
was	NULL
inhibited	NULL
specifically	NULL
by	NULL
the	NULL
unlabelled	NULL
probe	NULL
but	NULL
not	NULL
by	NULL
the	NULL
Xbal-Xhol	NULL
fragment	NULL
of	NULL
the	NULL
pKS	NULL
multiple	NULL
cloning	NULL
site	NULL
(	NULL
Fig	NULL
.	NULL

3	NULL
)	NULL
or	NULL
by	NULL
unlabelled	NULL
probes	NULL
from	NULL
the	NULL
other	NULL
functional	NULL
sites	NULL
of	NULL
the	NULL
promoter	NULL
used	NULL
for	NULL
cross-competition	NULL
(	NULL
data	NULL
not	NULL
shown	NULL
)	NULL
.	NULL

Sequence	NULL
requirements	NULL
for	NULL
transcription	NULL
initiation	NULL
of	NULL
the	NULL
CD4	NULL
gene	NULL
.	NULL

The	NULL
CD4	NULL
promoter	NULL
does	NULL
not	NULL
contain	NULL
a	NULL
consensus	NULL
TATA	NULL
recognition	NULL
sequence	NULL
.	NULL

Genes	NULL
without	NULL
TATA	NULL
sequences	NULL
are	NULL
often	NULL
controlled	NULL
by	NULL
initiator	NULL
(	NULL
Inr	NULL
)	NULL
sequences	NULL
present	NULL
at	NULL
the	NULL
cap	NULL
site	NULL
.	NULL

An	NULL
Inr	NULL
site	NULL
consists	NULL
primarily	NULL
of	NULL
a	NULL
core	NULL
YYANTYY	NULL
sequence	NULL
flanked	NULL
by	NULL
pyrimidines	NULL
(	NULL
15	NULL
)	NULL
.	NULL

The	NULL
sequence	NULL
encompassing	NULL
the	NULL
CD4	NULL
cap	NULL
site	NULL
(	NULL
TTCCTGTCTTTITCATTITA	NULL
)	NULL
contains	NULL
two	NULL
consensus	NULL
Inr	NULL
sites	NULL
:	NULL
a	NULL
downstream	NULL
site	NULL
surrounding	NULL
the	NULL
+7	NULL
start	NULL
site	NULL
(	NULL
TCATTTA	NULL
)	NULL
and	NULL
an	NULL
upstream	NULL
site	NULL
at	NULL
the	NULL
+1	NULL
start	NULL
site	NULL
(	NULL
TCTTTTC	NULL
)	NULL
.	NULL

Both	NULL
of	NULL
these	NULL
sites	NULL
have	NULL
a	NULL
1-base	NULL
mismatch	NULL
from	NULL
the	NULL
ideal	NULL
consensus	NULL
sequence	NULL
;	NULL
for	NULL
the	NULL
downstream	NULL
site	NULL
,	NULL
the	NULL
+5	NULL
pyrimidine	NULL
is	NULL
an	NULL
adenine	NULL
,	NULL
whereas	NULL
for	NULL
the	NULL
upstream	NULL
site	NULL
the	NULL
+1	NULL
site	NULL
is	NULL
a	NULL
pyrimidine	NULL
.	NULL

This	NULL
sequence	NULL
is	NULL
also	NULL
similar	NULL
to	NULL
a	NULL
consensus	NULL
lymphoid	NULL
enhancer	NULL
factor	NULL
1	NULL
(	NULL
LEF-1	NULL
)	NULL
recognition	NULL
site	NULL
(	NULL
CTNTG	NULL
[	NULL
46	NULL
]	NULL
)	NULL
,	NULL
and	NULL
we	NULL
were	NULL
able	NULL
to	NULL
footprint	NULL
this	NULL
region	NULL
by	NULL
using	NULL
bacterially	NULL
produced	NULL
LEF-1	NULL
protein	NULL
(	NULL
34	NULL
)	NULL
.	NULL

It	NULL
is	NULL
therefore	NULL
possible	NULL
that	NULL
either	NULL
Inr	NULL
proteins	NULL
or	NULL
LEF-1	NULL
itself	NULL
is	NULL
important	NULL
in	NULL
the	NULL
control	NULL
of	NULL
CD4	NULL
transcription	NULL
.	NULL

In	NULL
order	NULL
to	NULL
determine	NULL
if	NULL
the	NULL
recognition	NULL
site	NULL
at	NULL
the	NULL
CD4	NULL
cap	NULL
site	NULL
serves	NULL
functionally	NULL
as	NULL
an	NULL
Inr	NULL
site	NULL
or	NULL
an	NULL
LEF-1	NULL
site	NULL
,	NULL
we	NULL
generated	NULL
mutations	NULL
of	NULL
this	NULL
region	NULL
and	NULL
tested	NULL
each	NULL
mutation	NULL
for	NULL
its	NULL
effects	NULL
on	NULL
promoter	NULL
C.	NULL
)	NULL
Extract	NULL
+	NULL
+	NULL
+	NULL
Competitor	NULL
pkKs	NULL
S4	NULL
-	NULL
t+	NULL
+	NULL
+	NULL
Fold	NULL
excess	NULL
300	NULL
300	NULL
-	NULL
Ct	NULL
Â»	NULL
dap	NULL
fig	NULL
aos	NULL
-	NULL
$	NULL
3	NULL
pKs	NULL
-	NULL
300	NULL
300	NULL
FIG	NULL
.	NULL

3	NULL
.	NULL

EMSA	NULL
analysis	NULL
of	NULL
functionally	NULL
defined	NULL
sites	NULL
within	NULL
the	NULL
CD4	NULL
minimal	NULL
promoter	NULL
.	NULL

EMSA	NULL
analyses	NULL
with	NULL
D10	NULL
nuclear	NULL
extract	NULL
and	NULL
with	NULL
the	NULL
site	NULL
2	NULL
(	NULL
A	NULL
)	NULL
,	NULL
site	NULL
3	NULL
(	NULL
B	NULL
)	NULL
,	NULL
and	NULL
site	NULL
4	NULL
(	NULL
C	NULL
)	NULL
oligonucleotides	NULL
used	NULL
as	NULL
probes	NULL
.	NULL

The	NULL
position	NULL
of	NULL
the	NULL
specific	NULL
complex	NULL
formed	NULL
with	NULL
each	NULL
probe	NULL
(	NULL
arrows	NULL
)	NULL
is	NULL
indicated	NULL
.	NULL

Cold	NULL
competitions	NULL
with	NULL
the	NULL
site	NULL
2	NULL
(	NULL
S2	NULL
)	NULL
,	NULL
site	NULL
3	NULL
(	NULL
83	NULL
)	NULL
,	NULL
and	NULL
site	NULL
4	NULL
(	NULL
S4	NULL
)	NULL
oligonucleotides	NULL
and	NULL
competition	NULL
with	NULL
the	NULL
Xbal-Xhol	NULL
fragment	NULL
of	NULL
the	NULL
pKS	NULL
multiple	NULL
cloning	NULL
site	NULL
(	NULL
pKS	NULL
)	NULL
are	NULL
indicated	NULL
.	NULL

For	NULL
each	NULL
,	NULL
the	NULL
EMSA	NULL
reaction	NULL
consisted	NULL
of	NULL
a	NULL
20-min	NULL
preincubation	NULL
of	NULL
nuclear	NULL
extract	NULL
with	NULL
a	NULL
150-	NULL
to	NULL
300-fold	NULL
excess	NULL
of	NULL
an	NULL
unlabelled	NULL
probe	NULL
followed	NULL
by	NULL
an	NULL
additional	NULL
20-min	NULL
incubation	NULL
with	NULL
a	NULL
labelled	NULL
specific	NULL
probe	NULL
.	NULL

A	NULL
single	NULL
specific	NULL
complex	NULL
was	NULL
observed	NULL
with	NULL
each	NULL
of	NULL
the	NULL
subcloned	NULL
sites	NULL
.	NULL

3182	NULL
DUNCAN	NULL
ET	NULL
AL	NULL
.	NULL

Extract	NULL
RO	NULL
DRY	NULL
Jurkat	NULL
FIG	NULL
.	NULL

4	NULL
.	NULL

Footprint	NULL
analysis	NULL
of	NULL
functional	NULL
site	NULL
2	NULL
.	NULL

The	NULL
free	NULL
probe	NULL
is	NULL
shown	NULL
in	NULL
the	NULL
right	NULL
lane	NULL
(	NULL
None	NULL
)	NULL
;	NULL
the	NULL
probes	NULL
incubated	NULL
with	NULL
nuclear	NULL
extracts	NULL
purified	NULL
from	NULL
Jurkat	NULL
and	NULL
CCRF-CEM	NULL
T-cell	NULL
clones	NULL
are	NULL
shown	NULL
on	NULL
the	NULL
left	NULL
.	NULL

The	NULL
precise	NULL
position	NULL
of	NULL
the	NULL
footprint	NULL
and	NULL
its	NULL
position	NULL
within	NULL
the	NULL
CD4	NULL
promoter	NULL
are	NULL
indicated	NULL
by	NULL
the	NULL
bracket	NULL
and	NULL
sequence	NULL
position	NULL
numbers	NULL
.	NULL

function	NULL
(	NULL
Fig	NULL
.	NULL

1	NULL
)	NULL
.	NULL

The	NULL
murine	NULL
CD4	NULL
gene	NULL
utilizes	NULL
three	NULL
closely	NULL
clustered	NULL
initiation	NULL
points	NULL
of	NULL
transcription	NULL
.	NULL

Mutation	NULL
13	NULL
alters	NULL
the	NULL
+1	NULL
cap	NULL
site	NULL
and	NULL
the	NULL
upstream	NULL
consensus	NULL
initiator	NULL
sequence	NULL
.	NULL

As	NULL
can	NULL
be	NULL
seen	NULL
from	NULL
the	NULL
data	NULL
in	NULL
Fig	NULL
.	NULL

1	NULL
,	NULL
this	NULL
change	NULL
resulted	NULL
in	NULL
an	NULL
81	NULL
%	NULL
decrease	NULL
in	NULL
promoter	NULL
activity	NULL
,	NULL
indicating	NULL
that	NULL
the	NULL
mutation	NULL
of	NULL
this	NULL
region	NULL
is	NULL
critical	NULL
for	NULL
promoter	NULL
function	NULL
.	NULL

A	NULL
mutation	NULL
that	NULL
disrupts	NULL
the	NULL
consensus	NULL
initiator	NULL
and	NULL
LEF-1	NULL
sites	NULL
resulted	NULL
in	NULL
a	NULL
significant	NULL
(	NULL
61	NULL
%	NULL
)	NULL
decrease	NULL
in	NULL
promoter	NULL
activity	NULL
(	NULL
mutation	NULL
14	NULL
)	NULL
,	NULL
whereas	NULL
a	NULL
mutation	NULL
at	NULL
the	NULL
same	NULL
site	NULL
that	NULL
disrupts	NULL
the	NULL
LEF-1	NULL
site	NULL
but	NULL
not	NULL
the	NULL
consensus	NULL
initiator	NULL
sites	NULL
(	NULL
mutation	NULL
15	NULL
)	NULL
resulted	NULL
in	NULL
only	NULL
a	NULL
20	NULL
%	NULL
decrease	NULL
(	NULL
mutation	NULL
15	NULL
)	NULL
.	NULL

These	NULL
data	NULL
suggest	NULL
that	NULL
despite	NULL
the	NULL
presence	NULL
of	NULL
a	NULL
consensus	NULL
site	NULL
,	NULL
LEF-1	NULL
is	NULL
not	NULL
essential	NULL
for	NULL
CD4	NULL
promoter	NULL
function	NULL
.	NULL

Inter-estingly	NULL
,	NULL
mutations	NULL
of	NULL
the	NULL
+7	NULL
and	NULL
+11	NULL
cap	NULL
sites	NULL
and	NULL
surrounding	NULL
sequences	NULL
did	NULL
not	NULL
lead	NULL
to	NULL
significant	NULL
decreases	NULL
in	NULL
promoter	NULL
activity	NULL
and	NULL
in	NULL
fact	NULL
led	NULL
to	NULL
slight	NULL
increases	NULL
in	NULL
activity	NULL
(	NULL
mutations	NULL
16	NULL
and	NULL
17	NULL
)	NULL
.	NULL

These	NULL
data	NULL
suggest	NULL
that	NULL
the	NULL
+1	NULL
site	NULL
is	NULL
the	NULL
critical	NULL
site	NULL
for	NULL
CD4	NULL
transcript	NULL
initiation	NULL
.	NULL

A	NULL
T-cell	NULL
nuclear	NULL
factor	NULL
binds	NULL
to	NULL
functional	NULL
site	NULL
2	NULL
and	NULL
is	NULL
critical	NULL
for	NULL
CD4	NULL
promoter	NULL
function	NULL
.	NULL

Using	NULL
linker-scanning	NULL
analysis	NULL
,	NULL
we	NULL
determined	NULL
that	NULL
the	NULL
sequences	NULL
between	NULL
positions	NULL
-69	NULL
and	NULL
-64	NULL
are	NULL
required	NULL
for	NULL
full	NULL
CD4	NULL
promoter	NULL
function	NULL
(	NULL
Fig	NULL
.	NULL

1	NULL
)	NULL
.	NULL

A	NULL
mutation	NULL
placed	NULL
within	NULL
this	NULL
site	NULL
(	NULL
mutation	NULL
2	NULL
)	NULL
resulted	NULL
in	NULL
an	NULL
85	NULL
%	NULL
decrease	NULL
in	NULL
promoter	NULL
activity	NULL
,	NULL
whereas	NULL
mutations	NULL
in	NULL
directly	NULL
adjacent	NULL
regions	NULL
(	NULL
mutations	NULL
1	NULL
and	NULL
3	NULL
)	NULL
resulted	NULL
in	NULL
15	NULL
to	NULL
17	NULL
%	NULL
decreases	NULL
(	NULL
Fig	NULL
.	NULL

1	NULL
)	NULL
.	NULL

These	NULL
data	NULL
would	NULL
predict	NULL
that	NULL
a	NULL
transcription	NULL
factor	NULL
in	NULL
T	NULL
cells	NULL
binds	NULL
to	NULL
this	NULL
site	NULL
and	NULL
contributes	NULL
to	NULL
CD4	NULL
promoter	NULL
function	NULL
.	NULL

To	NULL
study	NULL
this	NULL
idea	NULL
,	NULL
we	NULL
conducted	NULL
DNase	NULL
footprinting	NULL
analysis	NULL
on	NULL
the	NULL
CD4	NULL
promoter	NULL
in	NULL
this	NULL
region	NULL
with	NULL
nuclear	NULL
extracts	NULL
purified	NULL
from	NULL
the	NULL
CCRF-CEM	NULL
and	NULL
Jurkat	NULL
CD4*	NULL
leukemic	NULL
T-cell	NULL
lines	NULL
and	NULL
with	NULL
the	NULL
D10	NULL
CD4*	NULL
CD8~	NULL
T	NULL
,	NULL
,	NULL
clone	NULL
(	NULL
Fig	NULL
.	NULL

4	NULL
)	NULL
.	NULL

We	NULL
detected	NULL
a	NULL
footprint	NULL
extending	NULL
from	NULL
-70	NULL
to	NULL
=65	NULL
of	NULL
the	NULL
promoter	NULL
(	NULL
TGGGAGGG	NULL
)	NULL
.	NULL

These	NULL
data	NULL
indicate	NULL
that	NULL
site	NULL
2	NULL
serves	NULL
as	NULL
a	NULL
recognition	NULL
site	NULL
for	NULL
a	NULL
nuclear	NULL
factor	NULL
that	NULL
may	NULL
be	NULL
important	NULL
for	NULL
overall	NULL
promoter	NULL
function	NULL
.	NULL

We	NULL
also	NULL
detected	NULL
a	NULL
specific	NULL
complex	NULL
when	NULL
we	NULL
used	NULL
site	NULL
2	NULL
as	NULL
a	NULL
radioactive	NULL
probe	NULL
in	NULL
EMSA	NULL
analyses	NULL
(	NULL
Fig	NULL
.	NULL

3	NULL
)	NULL
.	NULL

This	NULL
complex	NULL
migrates	NULL
in	NULL
the	NULL
EMSA	NULL
gel	NULL
at	NULL
the	NULL
same	NULL
position	NULL
as	NULL
the	NULL
NF-4C	NULL
factor	NULL
complex	NULL
that	NULL
we	NULL
identified	NULL
previously	NULL
as	NULL
binding	NULL
to	NULL
the	NULL
minimal	NULL
CD4	NULL
promoter	NULL
(	NULL
36	NULL
)	NULL
(	NULL
data	NULL
not	NULL
shown	NULL
)	NULL
.	NULL

When	NULL
a	NULL
radioactive	NULL
probe	NULL
containing	NULL
mutation	NULL
2	NULL
was	NULL
used	NULL
in	NULL
an	NULL
EMSA	NULL
,	NULL
this	NULL
complex	NULL
was	NULL
no	NULL
longer	NULL
detectable	NULL
(	NULL
Fig	NULL
.	NULL

5	NULL
)	NULL
,	NULL
thus	NULL
indicating	NULL
that	NULL
the	NULL
recognition	NULL
site	NULL
is	NULL
indeed	NULL
site	NULL
2	NULL
.	NULL

Since	NULL
this	NULL
same	NULL
mutation	NULL
resulted	NULL
in	NULL
a	NULL
significant	NULL
decrease	NULL
in	NULL
CD4	NULL
promoter	NULL
activity	NULL
(	NULL
Fig	NULL
.	NULL

1	NULL
)	NULL
,	NULL
these	NULL
data	NULL
indicate	NULL
that	NULL
the	NULL
NF-4C	NULL
nuclear	NULL
factor	NULL
Mor	NULL
.	NULL

CELL	NULL
.	NULL

BioL	NULL
.	NULL

Probe	NULL
+/+	NULL
M	NULL
@	NULL
Â©	NULL
Extract	NULL
5	NULL
2	NULL
Â¥	NULL
5	NULL
o	NULL
4	NULL
Z	NULL
Oo	NULL
Z	NULL
z	NULL
o	NULL
=	NULL
F	NULL
FIG	NULL
.	NULL

5	NULL
.	NULL

Nuclear	NULL
factor	NULL
binding	NULL
site	NULL
2	NULL
sequence	NULL
specificity	NULL
similarity	NULL
to	NULL
MAZ	NULL
.	NULL

Unmutated	NULL
(	NULL
+/+	NULL
)	NULL
and	NULL
mutated	NULL
(	NULL
M	NULL
)	NULL
site	NULL
2	NULL
probes	NULL
were	NULL
incubated	NULL
with	NULL
and	NULL
without	NULL
(	NULL
None	NULL
)	NULL
1	NULL
ug	NULL
of	NULL
nuclear	NULL
extract	NULL
of	NULL
D10	NULL
or	NULL
a	NULL
bacterial	NULL
lysate	NULL
containing	NULL
the	NULL
MAZ-MBP	NULL
fusion	NULL
protein	NULL
(	NULL
MAZ	NULL
)	NULL
.	NULL

binds	NULL
specifically	NULL
to	NULL
functional	NULL
site	NULL
2	NULL
and	NULL
is	NULL
required	NULL
for	NULL
full	NULL
CD4	NULL
promoter	NULL
function	NULL
.	NULL

In	NULL
some	NULL
EMSAs	NULL
,	NULL
we	NULL
detected	NULL
a	NULL
fainter	NULL
complex	NULL
that	NULL
migrated	NULL
just	NULL
below	NULL
the	NULL
NF-4C	NULL
complex	NULL
(	NULL
as	NULL
discussed	NULL
below	NULL
)	NULL
;	NULL
the	NULL
intensity	NULL
of	NULL
this	NULL
complex	NULL
was	NULL
not	NULL
affected	NULL
when	NULL
the	NULL
mutant	NULL
site	NULL
2	NULL
probe	NULL
was	NULL
used	NULL
.	NULL

This	NULL
result	NULL
indicates	NULL
that	NULL
the	NULL
factor	NULL
that	NULL
forms	NULL
this	NULL
fainter	NULL
complex	NULL
does	NULL
not	NULL
bind	NULL
to	NULL
functional	NULL
site	NULL
2	NULL
;	NULL
since	NULL
no	NULL
other	NULL
mutations	NULL
within	NULL
this	NULL
region	NULL
affect	NULL
CD4	NULL
promoter	NULL
function	NULL
(	NULL
Fig	NULL
.	NULL

1	NULL
)	NULL
,	NULL
the	NULL
significance	NULL
of	NULL
this	NULL
fainter	NULL
complex	NULL
is	NULL
not	NULL
clear	NULL
.	NULL

The	NULL
MAZ	NULL
transcription	NULL
factor	NULL
binds	NULL
to	NULL
site	NULL
2	NULL
.	NULL

To	NULL
determine	NULL
if	NULL
the	NULL
NF-4C	NULL
factor	NULL
has	NULL
been	NULL
identified	NULL
previously	NULL
,	NULL
we	NULL
have	NULL
compared	NULL
known	NULL
consensus	NULL
sequences	NULL
with	NULL
the	NULL
site	NULL
2	NULL
sequence	NULL
(	NULL
Fig	NULL
.	NULL

2	NULL
)	NULL
.	NULL

We	NULL
were	NULL
able	NULL
to	NULL
match	NULL
functional	NULL
site	NULL
2	NULL
with	NULL
the	NULL
consensus	NULL
recognition	NULL
site	NULL
for	NULL
transcription	NULL
factor	NULL
MAZ	NULL
(	NULL
2	NULL
,	NULL
5	NULL
)	NULL
.	NULL

In	NULL
order	NULL
to	NULL
determine	NULL
if	NULL
MAZ	NULL
can	NULL
recognize	NULL
functional	NULL
site	NULL
2	NULL
,	NULL
we	NULL
conducted	NULL
an	NULL
EMSA	NULL
,	NULL
using	NULL
a	NULL
bacterially	NULL
produced	NULL
MAZ-MBP	NULL
fusion	NULL
protein	NULL
with	NULL
the	NULL
functional	NULL
site	NULL
2	NULL
and	NULL
mutant	NULL
site	NULL
2	NULL
radioactive	NULL
probes	NULL
(	NULL
Fig	NULL
.	NULL

5	NULL
)	NULL
.	NULL

The	NULL
MAZ	NULL
fusion	NULL
protein	NULL
formed	NULL
a	NULL
complex	NULL
with	NULL
the	NULL
functional	NULL
site	NULL
2	NULL
probe	NULL
;	NULL
in	NULL
addition	NULL
,	NULL
introduction	NULL
of	NULL
the	NULL
same	NULL
mutation	NULL
that	NULL
abrogated	NULL
NF-4C	NULL
binding	NULL
also	NULL
abrogated	NULL
MAZ	NULL
binding	NULL
.	NULL

The	NULL
mobility	NULL
difference	NULL
between	NULL
the	NULL
endogenous	NULL
MAZ	NULL
and	NULL
the	NULL
recombinant	NULL
MBP-MAZ	NULL
fusion	NULL
protein	NULL
is	NULL
probably	NULL
due	NULL
to	NULL
the	NULL
molecular	NULL
weight	NULL
differences	NULL
between	NULL
these	NULL
two	NULL
proteins	NULL
.	NULL

These	NULL
data	NULL
indicate	NULL
that	NULL
MAZ	NULL
is	NULL
capable	NULL
of	NULL
binding	NULL
to	NULL
the	NULL
CD4	NULL
promoter	NULL
at	NULL
the	NULL
same	NULL
site	NULL
as	NULL
NF-4C	NULL
and	NULL
exhibits	NULL
sequence	NULL
specificity	NULL
in	NULL
binding	NULL
similar	NULL
to	NULL
that	NULL
of	NULL
NF-4C	NULL
.	NULL

As	NULL
described	NULL
above	NULL
,	NULL
this	NULL
mutation	NULL
caused	NULL
a	NULL
significant	NULL
decrease	NULL
in	NULL
CD4	NULL
promoter	NULL
function	NULL
;	NULL
these	NULL
data	NULL
are	NULL
thus	NULL
consistent	NULL
with	NULL
the	NULL
hypothesis	NULL
that	NULL
MAZ	NULL
binding	NULL
to	NULL
this	NULL
region	NULL
of	NULL
the	NULL
CD4	NULL
promoter	NULL
is	NULL
required	NULL
for	NULL
CD4	NULL
promoter	NULL
function	NULL
.	NULL

In	NULL
order	NULL
to	NULL
determine	NULL
the	NULL
molecular	NULL
weight	NULL
of	NULL
NF-4C	NULL
,	NULL
Southwestern	NULL
analysis	NULL
of	NULL
a	NULL
nuclear	NULL
extract	NULL
from	NULL
the	NULL
CD4*	NULL
CD8~	NULL
T-cell	NULL
line	NULL
Jurkat	NULL
was	NULL
done	NULL
with	NULL
the	NULL
site	NULL
2	NULL
probe	NULL
.	NULL

As	NULL
shown	NULL
in	NULL
Fig	NULL
.	NULL

6	NULL
(	NULL
left	NULL
lane	NULL
)	NULL
,	NULL
we	NULL
detected	NULL
two	NULL
proteins	NULL
with	NULL
the	NULL
site	NULL
2	NULL
probe	NULL
;	NULL
no	NULL
signal	NULL
was	NULL
seen	NULL
in	NULL
a	NULL
parallel	NULL
blot	NULL
probed	NULL
with	NULL
the	NULL
mutated	NULL
MAZ	NULL
site-CD4	NULL
promoter	NULL
probe	NULL
(	NULL
right	NULL
lane	NULL
)	NULL
or	NULL
Vou	NULL
.	NULL

15	NULL
,	NULL
1995	NULL
110KD	NULL
-	NULL
>	NULL
``	NULL
58KD	NULL
-	NULL
>	NULL
FIG	NULL
.	NULL

6	NULL
.	NULL

Southwestern	NULL
analysis	NULL
of	NULL
site	NULL
2	NULL
.	NULL

Twenty	NULL
micrograms	NULL
of	NULL
Jurkat	NULL
nuclear	NULL
extract	NULL
was	NULL
resolved	NULL
by	NULL
SDS-polyacrylamide	NULL
gel	NULL
electrophoresis	NULL
,	NULL
transferred	NULL
onto	NULL
a	NULL
nitrocellulose	NULL
membrane	NULL
and	NULL
hybridized	NULL
with	NULL
labelled	NULL
site	NULL
2	NULL
sequence	NULL
(	NULL
left	NULL
lane	NULL
)	NULL
or	NULL
a	NULL
labelled	NULL
control	NULL
probe	NULL
consisting	NULL
of	NULL
either	NULL
the	NULL
mutated	NULL
MAZ	NULL
CD4	NULL
promoter	NULL
site	NULL
(	NULL
right	NULL
lane	NULL
)	NULL
or	NULL
the	NULL
Xbal-Xhol	NULL
fragment	NULL
of	NULL
the	NULL
pKS	NULL
multiple	NULL
cloning	NULL
site	NULL
(	NULL
data	NULL
not	NULL
shown	NULL
)	NULL
.	NULL

Molecular	NULL
masses	NULL
were	NULL
determined	NULL
with	NULL
both	NULL
prestained	NULL
and	NULL
unstained	NULL
markers	NULL
.	NULL

No	NULL
signal	NULL
was	NULL
seen	NULL
with	NULL
either	NULL
the	NULL
mutated	NULL
MAZ	NULL
CD4	NULL
promoter	NULL
site	NULL
(	NULL
right	NULL
panel	NULL
)	NULL
or	NULL
the	NULL
plasmid	NULL
linker	NULL
control	NULL
probe	NULL
(	NULL
data	NULL
not	NULL
shown	NULL
)	NULL
.	NULL

The	NULL
two	NULL
proteins	NULL
detected	NULL
are	NULL
indicated	NULL
(	NULL
arrows	NULL
)	NULL
.	NULL

with	NULL
the	NULL
Xbal-Xhol	NULL
fragment	NULL
of	NULL
the	NULL
pKS	NULL
multiple	NULL
cloning	NULL
site	NULL
(	NULL
data	NULL
not	NULL
shown	NULL
)	NULL
.	NULL

The	NULL
smaller	NULL
complex	NULL
is	NULL
of	NULL
approximately	NULL
58	NULL
kDa	NULL
,	NULL
which	NULL
corresponds	NULL
closely	NULL
to	NULL
the	NULL
estimated	NULL
molecular	NULL
mass	NULL
of	NULL
MAZ	NULL
(	NULL
60	NULL
kDa	NULL
)	NULL
.	NULL

Thus	NULL
,	NULL
these	NULL
data	NULL
are	NULL
consistent	NULL
with	NULL
the	NULL
theory	NULL
that	NULL
MAZ	NULL
binds	NULL
to	NULL
site	NULL
2	NULL
.	NULL

The	NULL
larger	NULL
labelled	NULL
protein	NULL
had	NULL
a	NULL
molecular	NULL
mass	NULL
similar	NULL
to	NULL
that	NULL
of	NULL
Sp1	NULL
,	NULL
a	NULL
106-kDa	NULL
transcription	NULL
factor	NULL
which	NULL
recognizes	NULL
the	NULL
core	NULL
sequence	NULL
GGGCGG	NULL
(	NULL
17	NULL
)	NULL
.	NULL

Although	NULL
site	NULL
2	NULL
does	NULL
not	NULL
contain	NULL
a	NULL
high-affinity	NULL
recognition	NULL
site	NULL
for	NULL
Sp1	NULL
,	NULL
Spl	NULL
is	NULL
capable	NULL
of	NULL
binding	NULL
at	NULL
low	NULL
affinities	NULL
to	NULL
a	NULL
consensus	NULL
sequence	NULL
similar	NULL
to	NULL
site	NULL
2	NULL
(	NULL
17	NULL
)	NULL
.	NULL

However	NULL
,	NULL
the	NULL
alteration	NULL
of	NULL
the	NULL
central	NULL
cytosine	NULL
in	NULL
the	NULL
Sp1	NULL
recognition	NULL
sequence	NULL
has	NULL
been	NULL
shown	NULL
to	NULL
decrease	NULL
Spl	NULL
binding	NULL
significantly	NULL
(	NULL
37	NULL
)	NULL
;	NULL
in	NULL
our	NULL
investigations	NULL
,	NULL
it	NULL
has	NULL
been	NULL
difficult	NULL
to	NULL
show	NULL
consistent	NULL
Sp1	NULL
binding	NULL
to	NULL
site	NULL
2	NULL
(	NULL
Fig	NULL
.	NULL

3	NULL
and	NULL
5	NULL
and	NULL
data	NULL
not	NULL
shown	NULL
)	NULL
.	NULL

Nonetheless	NULL
,	NULL
it	NULL
is	NULL
possible	NULL
that	NULL
Spl	NULL
binds	NULL
to	NULL
functional	NULL
site	NULL
2	NULL
as	NULL
well	NULL
and	NULL
contributes	NULL
to	NULL
CD4	NULL
promoter	NULL
function	NULL
.	NULL

To	NULL
determine	NULL
if	NULL
MAZ	NULL
in	NULL
the	NULL
T-cell	NULL
nuclear	NULL
extracts	NULL
binds	NULL
to	NULL
the	NULL
CD4	NULL
promoter	NULL
,	NULL
we	NULL
conducted	NULL
antibody	NULL
ablation-supershift	NULL
experiments	NULL
using	NULL
D10	NULL
nuclear	NULL
extracts	NULL
and	NULL
a	NULL
monoclonal	NULL
antibody	NULL
directed	NULL
against	NULL
the	NULL
MAZ	NULL
transcription	NULL
factor	NULL
(	NULL
37	NULL
)	NULL
.	NULL

This	NULL
antibody	NULL
,	NULL
referred	NULL
to	NULL
as	NULL
antibody	NULL
80	NULL
,	NULL
does	NULL
not	NULL
recognize	NULL
the	NULL
zinc	NULL
finger	NULL
domain	NULL
of	NULL
MAZ	NULL
and	NULL
does	NULL
not	NULL
cross-react	NULL
with	NULL
Spl	NULL
(	NULL
26a	NULL
)	NULL
.	NULL

As	NULL
can	NULL
be	NULL
seen	NULL
from	NULL
Fig	NULL
.	NULL

7	NULL
,	NULL
the	NULL
specific	NULL
complex	NULL
observed	NULL
in	NULL
the	NULL
EMSA	NULL
analyses	NULL
of	NULL
site	NULL
2	NULL
was	NULL
completely	NULL
ablated	NULL
by	NULL
the	NULL
anti-MAZ	NULL
monoclonal	NULL
antibody	NULL
but	NULL
not	NULL
by	NULL
the	NULL
control	NULL
antibody	NULL
.	NULL

The	NULL
fainter	NULL
complex	NULL
migrating	NULL
below	NULL
the	NULL
NF-4C	NULL
complex	NULL
was	NULL
unaffected	NULL
by	NULL
the	NULL
antibody	NULL
treatment	NULL
;	NULL
together	NULL
with	NULL
the	NULL
data	NULL
showing	NULL
that	NULL
this	NULL
complex	NULL
forms	NULL
on	NULL
the	NULL
functionally	NULL
inactive	NULL
mutated	NULL
site	NULL
2	NULL
,	NULL
this	NULL
result	NULL
suggests	NULL
that	NULL
this	NULL
complex	NULL
is	NULL
nonspecific	NULL
and	NULL
irrelevant	NULL
to	NULL
promoter	NULL
function	NULL
.	NULL

We	NULL
have	NULL
used	NULL
the	NULL
ME1a1	NULL
site	NULL
from	NULL
the	NULL
c-myc	NULL
promoter	NULL
in	NULL
the	NULL
same	NULL
assay	NULL
;	NULL
this	NULL
site	NULL
is	NULL
a	NULL
known	NULL
MAZ	NULL
site	NULL
and	NULL
has	NULL
been	NULL
used	NULL
extensively	NULL
in	NULL
the	NULL
characterization	NULL
of	NULL
this	NULL
transcription	NULL
factor	NULL
.	NULL

In	NULL
this	NULL
experiment	NULL
,	NULL
we	NULL
also	NULL
detected	NULL
the	NULL
ablation	NULL
of	NULL
the	NULL
specific	NULL
MAZ	NULL
complex	NULL
(	NULL
data	NULL
not	NULL
shown	NULL
)	NULL
.	NULL

In	NULL
both	NULL
assays	NULL
,	NULL
the	NULL
MAZ	NULL
complexes	NULL
were	NULL
completely	NULL
ablated	NULL
,	NULL
indicating	NULL
that	NULL
the	NULL
complexes	NULL
formed	NULL
consist	NULL
entirely	NULL
of	NULL
MAZ	NULL
binding	NULL
to	NULL
the	NULL
probe	NULL
(	NULL
Fig	NULL
.	NULL

7	NULL
and	NULL
data	NULL
not	NULL
shown	NULL
)	NULL
.	NULL

DISCUSSION	NULL
At	NULL
least	NULL
four	NULL
distinct	NULL
transcription	NULL
factors	NULL
are	NULL
required	NULL
for	NULL
the	NULL
activity	NULL
of	NULL
the	NULL
CD4	NULL
minimal	NULL
promoter	NULL
.	NULL

Our	NULL
mutation	NULL
anal	NULL
A	NULL
MAZ	NULL
BINDING	NULL
SITE	NULL
IN	NULL
THE	NULL
CD4	NULL
PROMOTER	NULL
3183	NULL
N	NULL
4	NULL
8	NULL
Antibody	NULL
-	NULL
-	NULL
z	NULL
3	NULL
Â§	NULL
Q	NULL
2	NULL
2	NULL
?	NULL

9	NULL
4	NULL
<	NULL
Amount	NULL
-	NULL
=-	NULL
3	NULL
03	NULL
3	NULL
0.3	NULL
fused	NULL
Â«	NULL
cm	NULL
--	NULL
>	NULL
was	NULL
tuh	NULL
ts	NULL
FIG	NULL
.	NULL

7	NULL
.	NULL

Anti-MAZ	NULL
monoclonal	NULL
antibody	NULL
inhibits	NULL
factor	NULL
binding	NULL
to	NULL
site	NULL
2	NULL
.	NULL

Gel	NULL
shift	NULL
reaction	NULL
mixtures	NULL
with	NULL
site	NULL
2	NULL
and	NULL
D10	NULL
nuclear	NULL
extract	NULL
probes	NULL
were	NULL
prein-cubated	NULL
with	NULL
a	NULL
3-	NULL
or	NULL
0.3-4ul	NULL
volume	NULL
(	NULL
amount	NULL
)	NULL
of	NULL
the	NULL
anti-MAZ	NULL
monoclonal	NULL
antibody	NULL
80	NULL
culture	NULL
supernatant	NULL
(	NULL
AntiMAZ	NULL
)	NULL
or	NULL
isotype-matched	NULL
control	NULL
antibody	NULL
(	NULL
ISO	NULL
)	NULL
for	NULL
30	NULL
min	NULL
prior	NULL
to	NULL
the	NULL
addition	NULL
of	NULL
the	NULL
labelled	NULL
site	NULL
2	NULL
probe	NULL
.	NULL

The	NULL
leftmost	NULL
lane	NULL
contained	NULL
a	NULL
free	NULL
probe	NULL
,	NULL
and	NULL
the	NULL
next	NULL
lane	NULL
contained	NULL
the	NULL
EMSA	NULL
binding	NULL
reaction	NULL
mixture	NULL
with	NULL
the	NULL
site	NULL
2	NULL
probe	NULL
and	NULL
D10	NULL
nuclear	NULL
extract	NULL
without	NULL
the	NULL
addition	NULL
of	NULL
antibodies	NULL
.	NULL

The	NULL
arrow	NULL
indicates	NULL
the	NULL
position	NULL
of	NULL
the	NULL
specific	NULL
complex	NULL
.	NULL

yses	NULL
show	NULL
that	NULL
four	NULL
sites	NULL
within	NULL
the	NULL
CD4	NULL
minimal	NULL
promoter	NULL
,	NULL
each	NULL
serving	NULL
as	NULL
a	NULL
recognition	NULL
site	NULL
for	NULL
a	NULL
nuclear	NULL
factor	NULL
,	NULL
are	NULL
required	NULL
for	NULL
full	NULL
activity	NULL
.	NULL

We	NULL
have	NULL
previously	NULL
shown	NULL
that	NULL
the	NULL
Myb	NULL
recognition	NULL
sequences	NULL
at	NULL
site	NULL
1	NULL
are	NULL
essential	NULL
for	NULL
CD4	NULL
promoter	NULL
activity	NULL
(	NULL
36	NULL
)	NULL
;	NULL
in	NULL
addition	NULL
,	NULL
we	NULL
have	NULL
determined	NULL
that	NULL
c-Myb	NULL
can	NULL
bind	NULL
to	NULL
this	NULL
site	NULL
(	NULL
data	NULL
not	NULL
shown	NULL
)	NULL
.	NULL

Recently	NULL
,	NULL
Badiani	NULL
et	NULL
al	NULL
.	NULL

generated	NULL
transgenic	NULL
mice	NULL
by	NULL
using	NULL
constructs	NULL
that	NULL
contained	NULL
dominant-negative	NULL
forms	NULL
of	NULL
the	NULL
Myb	NULL
transcription	NULL
factor	NULL
(	NULL
3	NULL
)	NULL
.	NULL

These	NULL
transgenic	NULL
mice	NULL
show	NULL
significantly	NULL
decreased	NULL
populations	NULL
of	NULL
CD4~	NULL
CD8~	NULL
T	NULL
cells	NULL
both	NULL
in	NULL
the	NULL
thymus	NULL
and	NULL
in	NULL
peripheral	NULL
lymph	NULL
organs	NULL
;	NULL
CD4~	NULL
CD8	NULL
*	NULL
T	NULL
cells	NULL
were	NULL
less	NULL
affected	NULL
.	NULL

These	NULL
data	NULL
are	NULL
consistent	NULL
with	NULL
our	NULL
data	NULL
showing	NULL
that	NULL
the	NULL
two	NULL
Myb	NULL
binding	NULL
sites	NULL
in	NULL
the	NULL
CD4	NULL
promoter	NULL
are	NULL
required	NULL
for	NULL
full	NULL
promoter	NULL
function	NULL
in	NULL
mature	NULL
CD4	NULL
CD8~	NULL
T	NULL
cells	NULL
.	NULL

There	NULL
is	NULL
an	NULL
Ets	NULL
family	NULL
consensus	NULL
recognition	NULL
sequence	NULL
at	NULL
functional	NULL
site	NULL
4	NULL
.	NULL

Our	NULL
data	NULL
indicate	NULL
that	NULL
this	NULL
sequence	NULL
is	NULL
in	NULL
fact	NULL
critical	NULL
for	NULL
CD4	NULL
promoter	NULL
function	NULL
and	NULL
thus	NULL
are	NULL
supportive	NULL
of	NULL
the	NULL
hypothesis	NULL
that	NULL
an	NULL
Ets	NULL
transcription	NULL
factor	NULL
is	NULL
important	NULL
for	NULL
full	NULL
promoter	NULL
function	NULL
(	NULL
30	NULL
)	NULL
.	NULL

Using	NULL
UV	NULL
cross-linking	NULL
,	NULL
we	NULL
have	NULL
determined	NULL
that	NULL
multiple	NULL
factors	NULL
can	NULL
bind	NULL
this	NULL
region	NULL
,	NULL
all	NULL
with	NULL
molecular	NULL
weights	NULL
similar	NULL
to	NULL
those	NULL
of	NULL
Ets	NULL
transcription	NULL
factors	NULL
.	NULL

However	NULL
,	NULL
we	NULL
have	NULL
been	NULL
unable	NULL
to	NULL
demonstrate	NULL
serologically	NULL
that	NULL
either	NULL
Ets-1	NULL
or	NULL
Ets-2	NULL
binds	NULL
to	NULL
the	NULL
CD4	NULL
promoter	NULL
in	NULL
this	NULL
region	NULL
(	NULL
data	NULL
not	NULL
shown	NULL
)	NULL
.	NULL

It	NULL
is	NULL
therefore	NULL
possible	NULL
that	NULL
either	NULL
another	NULL
member	NULL
of	NULL
the	NULL
Ets	NULL
family	NULL
or	NULL
a	NULL
novel	NULL
transcription	NULL
factor	NULL
with	NULL
the	NULL
same	NULL
recognition	NULL
site	NULL
binds	NULL
site	NULL
4	NULL
and	NULL
contributes	NULL
to	NULL
CD4	NULL
promoter	NULL
function	NULL
.	NULL

We	NULL
are	NULL
currently	NULL
conducting	NULL
additional	NULL
experiments	NULL
to	NULL
address	NULL
these	NULL
issues	NULL
.	NULL

The	NULL
CD4	NULL
promoter	NULL
does	NULL
not	NULL
contain	NULL
a	NULL
functional	NULL
TATA	NULL
recognition	NULL
sequence	NULL
;	NULL
in	NULL
TATA-less	NULL
promoters	NULL
,	NULL
the	NULL
TFIID	NULL
complex	NULL
is	NULL
still	NULL
recruited	NULL
to	NULL
the	NULL
template	NULL
and	NULL
plays	NULL
an	NULL
important	NULL
role	NULL
in	NULL
transcription	NULL
initiation	NULL
(	NULL
27	NULL
)	NULL
.	NULL

This	NULL
role	NULL
is	NULL
believed	NULL
3184	NULL
DUNCAN	NULL
ET	NULL
AL	NULL
.	NULL

to	NULL
be	NULL
accomplished	NULL
by	NULL
protein-protein	NULL
interactions	NULL
between	NULL
TFIID	NULL
and	NULL
other	NULL
promoter-bound	NULL
transcription	NULL
factors	NULL
instead	NULL
of	NULL
by	NULL
direct	NULL
protein-DNA	NULL
interactions	NULL
with	NULL
the	NULL
TATA	NULL
box	NULL
.	NULL

The	NULL
TFIID	NULL
complex	NULL
is	NULL
still	NULL
believed	NULL
to	NULL
bind	NULL
to	NULL
the	NULL
promoter	NULL
,	NULL
in	NULL
approximately	NULL
the	NULL
same	NULL
position	NULL
relative	NULL
to	NULL
the	NULL
promoter	NULL
as	NULL
in	NULL
TATA-containing	NULL
promoters	NULL
(	NULL
27	NULL
)	NULL
.	NULL

Although	NULL
functional	NULL
site	NULL
3	NULL
is	NULL
5	NULL
'	NULL
to	NULL
this	NULL
region	NULL
,	NULL
it	NULL
may	NULL
nonetheless	NULL
represent	NULL
the	NULL
interaction	NULL
site	NULL
of	NULL
the	NULL
TFIID	NULL
complex	NULL
and	NULL
the	NULL
CD4	NULL
promoter	NULL
.	NULL

Alterna-tively	NULL
,	NULL
this	NULL
region	NULL
could	NULL
represent	NULL
the	NULL
binding	NULL
sites	NULL
of	NULL
transcription	NULL
factors	NULL
that	NULL
have	NULL
yet	NULL
to	NULL
be	NULL
identified	NULL
.	NULL

We	NULL
are	NULL
currently	NULL
conducting	NULL
experiments	NULL
to	NULL
address	NULL
these	NULL
questions	NULL
.	NULL

The	NULL
MAZ	NULL
recognition	NULL
site	NULL
is	NULL
critical	NULL
for	NULL
CD4	NULL
promoter	NULL
function	NULL
.	NULL

We	NULL
demonstrate	NULL
that	NULL
a	NULL
recognition	NULL
site	NULL
for	NULL
MAZ	NULL
in	NULL
the	NULL
minimal	NULL
CD4	NULL
promoter	NULL
is	NULL
essential	NULL
for	NULL
promoter	NULL
activity	NULL
.	NULL

In	NULL
addition	NULL
,	NULL
we	NULL
have	NULL
demonstrated	NULL
that	NULL
MAZ	NULL
in	NULL
CD4*	NULL
CD8~	NULL
T	NULL
;	NULL
cell	NULL
nuclear	NULL
extracts	NULL
recognizes	NULL
this	NULL
site	NULL
and	NULL
a	NULL
mutation	NULL
that	NULL
abrogates	NULL
promoter	NULL
activity	NULL
also	NULL
abrogates	NULL
MAZ	NULL
binding	NULL
.	NULL

From	NULL
these	NULL
data	NULL
,	NULL
we	NULL
conclude	NULL
that	NULL
it	NULL
is	NULL
likely	NULL
that	NULL
MAZ	NULL
plays	NULL
an	NULL
important	NULL
role	NULL
in	NULL
CD4	NULL
gene	NULL
transcription	NULL
.	NULL

The	NULL
MAZ	NULL
transcription	NULL
factor	NULL
binds	NULL
to	NULL
the	NULL
c-myc	NULL
P2	NULL
promoter	NULL
at	NULL
the	NULL
MElal	NULL
site	NULL
,	NULL
which	NULL
is	NULL
essential	NULL
for	NULL
the	NULL
control	NULL
of	NULL
transcriptional	NULL
initiation	NULL
and	NULL
elongation	NULL
(	NULL
2	NULL
,	NULL
22	NULL
,	NULL
47	NULL
)	NULL
.	NULL

Our	NULL
data	NULL
indicate	NULL
that	NULL
CD4	NULL
expression	NULL
is	NULL
also	NULL
likely	NULL
controlled	NULL
by	NULL
this	NULL
transcription	NULL
factor	NULL
,	NULL
and	NULL
thus	NULL
MAZ	NULL
can	NULL
also	NULL
participate	NULL
in	NULL
the	NULL
control	NULL
of	NULL
transcription	NULL
of	NULL
genes	NULL
that	NULL
are	NULL
differentially	NULL
expressed	NULL
in	NULL
lymphoid	NULL
development	NULL
.	NULL

Our	NULL
EMSA	NULL
analysis	NULL
under	NULL
the	NULL
conditions	NULL
described	NULL
clearly	NULL
demonstrates	NULL
that	NULL
one	NULL
predominant	NULL
complex	NULL
is	NULL
formed	NULL
by	NULL
using	NULL
the	NULL
site	NULL
2	NULL
probe	NULL
and	NULL
crude	NULL
nuclear	NULL
extract	NULL
from	NULL
CD4*	NULL
CD8~	NULL
T	NULL
;	NULL
,	NULL
D10	NULL
cells	NULL
.	NULL

However	NULL
,	NULL
other	NULL
transcription	NULL
factors	NULL
have	NULL
been	NULL
shown	NULL
to	NULL
bind	NULL
to	NULL
MAZ	NULL
recognition	NULL
sequences	NULL
.	NULL

As	NULL
mentioned	NULL
above	NULL
,	NULL
Spl	NULL
can	NULL
also	NULL
bind	NULL
to	NULL
the	NULL
MElal	NULL
site	NULL
under	NULL
certain	NULL
EMSA	NULL
conditions	NULL
.	NULL

Recently	NULL
,	NULL
Dufort	NULL
and	NULL
Nepveu	NULL
(	NULL
9	NULL
)	NULL
demonstrated	NULL
that	NULL
a	NULL
human	NULL
homolog	NULL
of	NULL
the	NULL
Drosophile	NULL
Cut	NULL
homeodomain	NULL
protein	NULL
also	NULL
binds	NULL
to	NULL
this	NULL
site	NULL
and	NULL
represses	NULL
c-mye	NULL
promoter	NULL
function	NULL
.	NULL

Our	NULL
data	NULL
indicate	NULL
that	NULL
the	NULL
MAZ	NULL
transcription	NULL
factor	NULL
is	NULL
clearly	NULL
the	NULL
major	NULL
factor	NULL
binding	NULL
to	NULL
the	NULL
CD4	NULL
promoter	NULL
at	NULL
site	NULL
2	NULL
.	NULL

It	NULL
is	NULL
possible	NULL
,	NULL
however	NULL
,	NULL
that	NULL
these	NULL
other	NULL
ME1al-site-binding	NULL
transcription	NULL
factors	NULL
bind	NULL
to	NULL
the	NULL
CD4	NULL
promoter	NULL
region	NULL
under	NULL
different	NULL
contexts	NULL
.	NULL

We	NULL
and	NULL
others	NULL
have	NULL
previously	NULL
demonstrated	NULL
that	NULL
the	NULL
CD4	NULL
promoter	NULL
is	NULL
functional	NULL
at	NULL
high	NULL
levels	NULL
in	NULL
activated	NULL
mature	NULL
CD4*	NULL
CD8~	NULL
T	NULL
cells	NULL
(	NULL
30	NULL
,	NULL
36	NULL
)	NULL
.	NULL

The	NULL
biochemical	NULL
nature	NULL
of	NULL
this	NULL
specificity	NULL
is	NULL
unknown	NULL
;	NULL
however	NULL
,	NULL
it	NULL
is	NULL
also	NULL
possible	NULL
that	NULL
MAZ	NULL
and	NULL
these	NULL
other	NULL
transcription	NULL
factors	NULL
play	NULL
a	NULL
role	NULL
.	NULL

For	NULL
example	NULL
,	NULL
it	NULL
is	NULL
possible	NULL
that	NULL
the	NULL
mammalian	NULL
homolog	NULL
of	NULL
the	NULL
Cut	NULL
homeodomain	NULL
protein	NULL
also	NULL
binds	NULL
to	NULL
site	NULL
2	NULL
and	NULL
that	NULL
its	NULL
expression	NULL
in	NULL
CD4~	NULL
CD8	NULL
*	NULL
T..	NULL
cells	NULL
provides	NULL
a	NULL
mechanism	NULL
for	NULL
this	NULL
subclass	NULL
specificity	NULL
.	NULL

We	NULL
are	NULL
currently	NULL
conducting	NULL
experiments	NULL
to	NULL
address	NULL
these	NULL
issues	NULL
.	NULL

Potential	NULL
roles	NULL
of	NULL
MAZ	NULL
in	NULL
CD4	NULL
promoter	NULL
function	NULL
.	NULL

We	NULL
have	NULL
demonstrated	NULL
that	NULL
the	NULL
MAZ	NULL
transcription	NULL
factor	NULL
binds	NULL
specifically	NULL
to	NULL
the	NULL
CD4	NULL
promoter	NULL
at	NULL
a	NULL
site	NULL
that	NULL
is	NULL
critical	NULL
for	NULL
function	NULL
.	NULL

We	NULL
therefore	NULL
think	NULL
it	NULL
likely	NULL
that	NULL
MAZ	NULL
plays	NULL
an	NULL
important	NULL
role	NULL
in	NULL
CD4	NULL
gene	NULL
transcription	NULL
.	NULL

Other	NULL
groups	NULL
have	NULL
reported	NULL
that	NULL
MAZ	NULL
can	NULL
transactivate	NULL
the	NULL
insulin	NULL
promoter	NULL
in	NULL
both	NULL
insuli-noma	NULL
and	NULL
HeLa	NULL
cells	NULL
(	NULL
18	NULL
)	NULL
.	NULL

However	NULL
,	NULL
we	NULL
have	NULL
been	NULL
unable	NULL
to	NULL
demonstrate	NULL
similar	NULL
transactivation	NULL
in	NULL
T	NULL
cells	NULL
by	NULL
using	NULL
the	NULL
CD4	NULL
promoter	NULL
.	NULL

There	NULL
are	NULL
several	NULL
possible	NULL
explanations	NULL
for	NULL
these	NULL
results	NULL
.	NULL

First	NULL
,	NULL
it	NULL
is	NULL
possible	NULL
that	NULL
a	NULL
factor	NULL
other	NULL
than	NULL
MAZ	NULL
is	NULL
binding	NULL
to	NULL
the	NULL
CD4	NULL
promoter	NULL
and	NULL
is	NULL
required	NULL
for	NULL
promoter	NULL
activity	NULL
.	NULL

Although	NULL
this	NULL
is	NULL
a	NULL
formal	NULL
possibility	NULL
,	NULL
it	NULL
should	NULL
be	NULL
noted	NULL
that	NULL
we	NULL
have	NULL
been	NULL
unable	NULL
to	NULL
detect	NULL
other	NULL
factors	NULL
binding	NULL
to	NULL
the	NULL
CD4	NULL
promoter	NULL
at	NULL
this	NULL
site	NULL
under	NULL
a	NULL
variety	NULL
of	NULL
conditions	NULL
in	NULL
EMSAs	NULL
and	NULL
we	NULL
therefore	NULL
consider	NULL
this	NULL
unlikely	NULL
.	NULL

Second	NULL
,	NULL
by	NULL
Northern	NULL
(	NULL
RNA	NULL
)	NULL
analysis	NULL
MAZ	NULL
is	NULL
expressed	NULL
at	NULL
high	NULL
levels	NULL
in	NULL
T	NULL
cells	NULL
(	NULL
data	NULL
not	NULL
shown	NULL
)	NULL
.	NULL

It	NULL
is	NULL
thus	NULL
possible	NULL
either	NULL
that	NULL
MAZ	NULL
is	NULL
not	NULL
limiting	NULL
in	NULL
CD4	NULL
promoter	NULL
function	NULL
or	NULL
that	NULL
the	NULL
high	NULL
levels	NULL
of	NULL
Mor	NULL
.	NULL

CELL	NULL
.	NULL

BioL	NULL
.	NULL

MAZ	NULL
make	NULL
it	NULL
difficult	NULL
to	NULL
observe	NULL
transactivation	NULL
in	NULL
these	NULL
transient	NULL
transfection	NULL
experiments	NULL
.	NULL

A	NULL
third	NULL
possibility	NULL
,	NULL
however	NULL
,	NULL
is	NULL
that	NULL
MAZ	NULL
is	NULL
not	NULL
acting	NULL
directly	NULL
as	NULL
a	NULL
transcriptional	NULL
activator	NULL
but	NULL
rather	NULL
induces	NULL
a	NULL
bend	NULL
in	NULL
the	NULL
DNA	NULL
helix	NULL
,	NULL
facilitating	NULL
interactions	NULL
between	NULL
other	NULL
promoter-binding	NULL
factors	NULL
.	NULL

Recently	NULL
,	NULL
it	NULL
has	NULL
been	NULL
reported	NULL
that	NULL
MAZ	NULL
is	NULL
capable	NULL
of	NULL
inducing	NULL
a	NULL
72Â°C	NULL
bend	NULL
in	NULL
the	NULL
DNA	NULL
helix	NULL
upon	NULL
binding	NULL
to	NULL
its	NULL
recognition	NULL
site	NULL
,	NULL
which	NULL
is	NULL
consistent	NULL
with	NULL
this	NULL
last	NULL
theory	NULL
(	NULL
1	NULL
)	NULL
.	NULL

Several	NULL
transcription	NULL
factors	NULL
that	NULL
induce	NULL
bending	NULL
of	NULL
DNA	NULL
to	NULL
affect	NULL
promoter/	NULL
enhancer	NULL
function	NULL
have	NULL
been	NULL
identified	NULL
,	NULL
including	NULL
YY1	NULL
(	NULL
23	NULL
)	NULL
and	NULL
HMG	NULL
I/	NULL
(	NULL
Y	NULL
)	NULL
(	NULL
40	NULL
)	NULL
.	NULL

A	NULL
well-studied	NULL
example	NULL
of	NULL
this	NULL
type	NULL
of	NULL
transcription	NULL
factor	NULL
is	NULL
LEF-1	NULL
(	NULL
41	NULL
,	NULL
45	NULL
,	NULL
46	NULL
)	NULL
,	NULL
which	NULL
binds	NULL
to	NULL
the	NULL
T-cell	NULL
antigen	NULL
receptor	NULL
Â«	NULL
-chain	NULL
enhancer	NULL
and	NULL
generates	NULL
a	NULL
130Â°	NULL
bend	NULL
in	NULL
the	NULL
DNA	NULL
helix	NULL
.	NULL

Multimerized	NULL
LEF-1	NULL
binding	NULL
sites	NULL
are	NULL
not	NULL
themselves	NULL
sufficient	NULL
to	NULL
stimulate	NULL
the	NULL
basal	NULL
activity	NULL
of	NULL
a	NULL
heterologous	NULL
fos	NULL
or	NULL
tk	NULL
promoter	NULL
,	NULL
indicating	NULL
that	NULL
LEF-1	NULL
is	NULL
dependent	NULL
upon	NULL
other	NULL
transcriptional	NULL
regulators	NULL
to	NULL
generate	NULL
a	NULL
biological	NULL
effect	NULL
.	NULL

Finally	NULL
,	NULL
changes	NULL
in	NULL
the	NULL
spacing	NULL
distance	NULL
between	NULL
factor	NULL
binding	NULL
sites	NULL
in	NULL
the	NULL
Â«	NULL
-chain	NULL
enhancer	NULL
decrease	NULL
enhancer	NULL
function	NULL
significantly	NULL
,	NULL
indicating	NULL
that	NULL
the	NULL
spacing	NULL
distance	NULL
and	NULL
the	NULL
corresponding	NULL
helical	NULL
position	NULL
of	NULL
the	NULL
LEF-1	NULL
site	NULL
with	NULL
respect	NULL
to	NULL
the	NULL
other	NULL
factor	NULL
binding	NULL
sites	NULL
are	NULL
critical	NULL
for	NULL
enhancer	NULL
function	NULL
.	NULL

It	NULL
is	NULL
interesting	NULL
that	NULL
although	NULL
there	NULL
are	NULL
multiple	NULL
MAZ	NULL
consensus	NULL
recognition	NULL
sites	NULL
adjacent	NULL
to	NULL
each	NULL
other	NULL
in	NULL
the	NULL
CD4	NULL
promoter	NULL
,	NULL
only	NULL
one	NULL
of	NULL
the	NULL
sites	NULL
appears	NULL
to	NULL
be	NULL
required	NULL
for	NULL
CD4	NULL
promoter	NULL
function	NULL
.	NULL

In	NULL
addition	NULL
to	NULL
the	NULL
core	NULL
MAZ	NULL
site	NULL
described	NULL
above	NULL
at	NULL
positions	NULL
-71	NULL
to	NULL
-65	NULL
,	NULL
there	NULL
is	NULL
a	NULL
consensus	NULL
MAZ	NULL
site	NULL
from	NULL
-77	NULL
to	NULL
-69	NULL
and	NULL
one	NULL
at	NULL
-67	NULL
to	NULL
-61	NULL
.	NULL

Despite	NULL
the	NULL
sequence	NULL
similarity	NULL
,	NULL
neither	NULL
of	NULL
these	NULL
last	NULL
two	NULL
sites	NULL
appears	NULL
to	NULL
function	NULL
as	NULL
an	NULL
MAZ	NULL
recognition	NULL
site	NULL
in	NULL
that	NULL
the	NULL
mutation	NULL
of	NULL
either	NULL
site	NULL
does	NULL
not	NULL
appear	NULL
to	NULL
affect	NULL
promoter	NULL
function	NULL
.	NULL

Thus	NULL
,	NULL
either	NULL
the	NULL
-71	NULL
to	NULL
-65	NULL
MAZ	NULL
recognition	NULL
site	NULL
has	NULL
sequence-specific	NULL
requirements	NULL
that	NULL
are	NULL
not	NULL
evident	NULL
in	NULL
other	NULL
MAZ	NULL
sites	NULL
or	NULL
,	NULL
as	NULL
in	NULL
the	NULL
LEF-1	NULL
site	NULL
in	NULL
the	NULL
Â«	NULL
-chain	NULL
enhancer	NULL
,	NULL
the	NULL
position	NULL
of	NULL
this	NULL
site	NULL
relative	NULL
to	NULL
the	NULL
other	NULL
factor	NULL
binding	NULL
sites	NULL
is	NULL
critical	NULL
for	NULL
function	NULL
.	NULL

This	NULL
last	NULL
hypothesis	NULL
is	NULL
consistent	NULL
with	NULL
the	NULL
theory	NULL
that	NULL
MAZ	NULL
is	NULL
playing	NULL
a	NULL
structural	NULL
role	NULL
in	NULL
CD4	NULL
promoter	NULL
function	NULL
.	NULL

Further	NULL
experiments	NULL
will	NULL
more	NULL
directly	NULL
address	NULL
this	NULL
issue	NULL
.	NULL

A	NULL
potential	NULL
initiator	NULL
recognition	NULL
sequence	NULL
at	NULL
the	NULL
CD4	NULL
cap	NULL
site	NULL
.	NULL

Sequence	NULL
analysis	NULL
indicates	NULL
that	NULL
there	NULL
are	NULL
potential	NULL
initiator	NULL
and	NULL
LEF-1	NULL
consensus	NULL
recognition	NULL
sites	NULL
at	NULL
the	NULL
CD4	NULL
initiation	NULL
point	NULL
of	NULL
transcription	NULL
.	NULL

The	NULL
results	NULL
of	NULL
our	NULL
mutagenesis	NULL
analyses	NULL
are	NULL
consistent	NULL
with	NULL
the	NULL
hypothesis	NULL
that	NULL
an	NULL
initiator	NULL
factor	NULL
binds	NULL
to	NULL
the	NULL
CD4	NULL
cap	NULL
site	NULL
and	NULL
is	NULL
responsible	NULL
in	NULL
part	NULL
for	NULL
CD4	NULL
transcript	NULL
initiation	NULL
.	NULL

Using	NULL
the	NULL
TdT	NULL
promoter	NULL
as	NULL
a	NULL
model	NULL
system	NULL
,	NULL
Javahery	NULL
et	NULL
al	NULL
.	NULL

determined	NULL
that	NULL
a	NULL
consensus	NULL
recognition	NULL
sequence	NULL
of	NULL
YYANTYY	NULL
around	NULL
the	NULL
initiation	NULL
point	NULL
of	NULL
transcription	NULL
was	NULL
critical	NULL
for	NULL
Inr	NULL
function	NULL
(	NULL
15	NULL
)	NULL
.	NULL

In	NULL
the	NULL
CD4	NULL
promoter	NULL
,	NULL
the	NULL
best	NULL
consensus	NULL
Inr	NULL
recognition	NULL
sequence	NULL
has	NULL
the	NULL
central	NULL
adenine	NULL
base	NULL
at	NULL
position	NULL
+7	NULL
instead	NULL
of	NULL
the	NULL
customary	NULL
+1	NULL
;	NULL
however	NULL
,	NULL
previous	NULL
analyses	NULL
have	NULL
indicated	NULL
that	NULL
Int	NULL
is	NULL
functional	NULL
even	NULL
though	NULL
the	NULL
recognition	NULL
is	NULL
shifted	NULL
slightly	NULL
from	NULL
the	NULL
actual	NULL
start	NULL
site	NULL
.	NULL

However	NULL
,	NULL
the	NULL
disruption	NULL
of	NULL
this	NULL
site	NULL
does	NULL
not	NULL
lead	NULL
to	NULL
decreased	NULL
promoter	NULL
function	NULL
,	NULL
whereas	NULL
the	NULL
mutation	NULL
of	NULL
an	NULL
upstream	NULL
putative	NULL
Inr	NULL
site	NULL
surrounding	NULL
the	NULL
+1	NULL
cap	NULL
site	NULL
(	NULL
TCTTITC	NULL
)	NULL
results	NULL
in	NULL
a	NULL
significant	NULL
decrease	NULL
in	NULL
the	NULL
level	NULL
of	NULL
promoter	NULL
activity	NULL
.	NULL

These	NULL
data	NULL
indicate	NULL
that	NULL
only	NULL
the	NULL
upstream	NULL
site	NULL
functions	NULL
as	NULL
an	NULL
in	NULL
vivo	NULL
Inr	NULL
recognition	NULL
site	NULL
.	NULL

However	NULL
,	NULL
it	NULL
is	NULL
necessary	NULL
to	NULL
conduct	NULL
a	NULL
more	NULL
thorough	NULL
analysis	NULL
of	NULL
the	NULL
start	NULL
sites	NULL
of	NULL
each	NULL
individual	NULL
mutant	NULL
before	NULL
this	NULL
function	NULL
is	NULL
conclusively	NULL
demonstrated	NULL
.	NULL

We	NULL
are	NULL
also	NULL
currently	NULL
conducting	NULL
experiments	NULL
to	NULL
characterize	NULL
the	NULL
factors	NULL
that	NULL
recognize	NULL
these	NULL
putative	NULL
Inr	NULL
sites	NULL
and	NULL
contribute	NULL
to	NULL
CD4	NULL
promoter	NULL
function	NULL
.	NULL

Role	NULL
of	NULL
the	NULL
promoter	NULL
in	NULL
control	NULL
of	NULL
CD4	NULL
gene	NULL
expression	NULL
.	NULL

In	NULL
addition	NULL
to	NULL
the	NULL
promoter	NULL
,	NULL
at	NULL
least	NULL
two	NULL
enhancers	NULL
and	NULL
a	NULL
tran	NULL
Vou	NULL
.	NULL

15	NULL
,	NULL
1995	NULL
scriptional	NULL
silencer	NULL
participate	NULL
in	NULL
the	NULL
control	NULL
of	NULL
CD4	NULL
gene	NULL
expression	NULL
(	NULL
36	NULL
)	NULL
.	NULL

From	NULL
transfection	NULL
studies	NULL
and	NULL
transgenic	NULL
data	NULL
,	NULL
we	NULL
have	NULL
developed	NULL
a	NULL
hierarchy	NULL
model	NULL
of	NULL
the	NULL
functional	NULL
relation	NULL
among	NULL
these	NULL
three	NULL
regulatory	NULL
components	NULL
of	NULL
the	NULL
CD4	NULL
locus	NULL
.	NULL

As	NULL
mentioned	NULL
above	NULL
,	NULL
promoter	NULL
activity	NULL
is	NULL
restricted	NULL
to	NULL
activated	NULL
CD4	NULL
*	NULL
T	NULL
cells	NULL
and	NULL
is	NULL
sufficient	NULL
to	NULL
generate	NULL
high	NULL
levels	NULL
of	NULL
activity	NULL
(	NULL
3	NULL
,	NULL
14	NULL
,	NULL
36	NULL
)	NULL
.	NULL

The	NULL
enhancers	NULL
extend	NULL
expression	NULL
to	NULL
other	NULL
T-cell	NULL
compartments	NULL
(	NULL
mature	NULL
CD4~	NULL
CD8*	NULL
T	NULL
cells	NULL
,	NULL
immature	NULL
CD4*	NULL
CD8*	NULL
T	NULL
cells	NULL
,	NULL
and	NULL
immature	NULL
CD4~	NULL
CD8~	NULL
T	NULL
cells	NULL
)	NULL
and	NULL
potentially	NULL
to	NULL
other	NULL
hematopoietic	NULL
cells	NULL
(	NULL
4	NULL
,	NULL
31	NULL
,	NULL
35	NULL
,	NULL
49	NULL
)	NULL
.	NULL

Thus	NULL
,	NULL
the	NULL
net	NULL
effect	NULL
of	NULL
the	NULL
two	NULL
enhancers	NULL
is	NULL
to	NULL
overrule	NULL
the	NULL
specificity	NULL
of	NULL
the	NULL
promoter	NULL
and	NULL
extend	NULL
expression	NULL
to	NULL
other	NULL
hematopoietic	NULL
cells	NULL
.	NULL

Finally	NULL
,	NULL
the	NULL
silencer	NULL
suppresses	NULL
enhancer	NULL
activity	NULL
and	NULL
inhibits	NULL
expression	NULL
of	NULL
CD4	NULL
in	NULL
inappropriate	NULL
cell	NULL
types	NULL
.	NULL

This	NULL
model	NULL
proposes	NULL
that	NULL
the	NULL
silencer	NULL
is	NULL
active	NULL
in	NULL
CD4~	NULL
T	NULL
cells	NULL
and	NULL
non-T	NULL
cells	NULL
,	NULL
but	NULL
inactive	NULL
in	NULL
â¬CD4*~	NULL
CD8	NULL
*	NULL
T	NULL
cells	NULL
,	NULL
whose	NULL
expression	NULL
is	NULL
a	NULL
function	NULL
of	NULL
enhancer-promoter	NULL
interactions	NULL
.	NULL

Our	NULL
analysis	NULL
of	NULL
the	NULL
CD4	NULL
promoter	NULL
and	NULL
the	NULL
experiments	NULL
using	NULL
c-Myb	NULL
dominant-negative	NULL
transgenic	NULL
mice	NULL
(	NULL
3	NULL
)	NULL
permit	NULL
us	NULL
to	NULL
elaborate	NULL
on	NULL
the	NULL
hierarchy	NULL
model	NULL
.	NULL

Because	NULL
the	NULL
promoter	NULL
is	NULL
the	NULL
critical	NULL
controlling	NULL
element	NULL
for	NULL
CD4	NULL
expression	NULL
in	NULL
mature	NULL
CD4*	NULL
CD8~	NULL
T	NULL
cells	NULL
,	NULL
the	NULL
inhibition	NULL
of	NULL
function	NULL
of	NULL
a	NULL
promoter-binding	NULL
factor	NULL
such	NULL
as	NULL
c-Myb	NULL
or	NULL
MAZ	NULL
will	NULL
disable	NULL
CD4	NULL
expression	NULL
in	NULL
these	NULL
cells	NULL
despite	NULL
the	NULL
presence	NULL
of	NULL
the	NULL
enhancers	NULL
.	NULL

In	NULL
mice	NULL
transgenic	NULL
for	NULL
the	NULL
dominant-negative	NULL
c-Myb	NULL
construct	NULL
,	NULL
the	NULL
CD4*	NULL
CD8~	NULL
T-cell	NULL
populations	NULL
were	NULL
affected	NULL
far	NULL
more	NULL
severely	NULL
than	NULL
the	NULL
other	NULL
T-cell	NULL
populations	NULL
.	NULL

In	NULL
addition	NULL
,	NULL
T-cell	NULL
activation	NULL
was	NULL
profoundly	NULL
affected	NULL
.	NULL

Thus	NULL
,	NULL
although	NULL
the	NULL
dominant-negative	NULL
form	NULL
of	NULL
Myb	NULL
inhibits	NULL
CD4	NULL
expression	NULL
and	NULL
subsequent	NULL
T-cell	NULL
development	NULL
in	NULL
all	NULL
classes	NULL
of	NULL
T	NULL
cells	NULL
,	NULL
the	NULL
effect	NULL
is	NULL
most	NULL
pronounced	NULL
in	NULL
the	NULL
CD4*	NULL
CD8~	NULL
mature	NULL
T-cell	NULL
popu-lations	NULL
,	NULL
which	NULL
is	NULL
consistent	NULL
with	NULL
the	NULL
hierarchy	NULL
model	NULL
.	NULL

Despite	NULL
the	NULL
ability	NULL
of	NULL
the	NULL
enhancers	NULL
and	NULL
the	NULL
silencer	NULL
to	NULL
alter	NULL
the	NULL
specificity	NULL
of	NULL
the	NULL
promoter	NULL
,	NULL
these	NULL
data	NULL
clearly	NULL
demonstrate	NULL
that	NULL
the	NULL
promoter	NULL
is	NULL
still	NULL
a	NULL
critical	NULL
element	NULL
in	NULL
the	NULL
control	NULL
of	NULL
CD4	NULL
gene	NULL
expression	NULL
.	NULL

We	NULL
are	NULL
currently	NULL
conducting	NULL
additional	NULL
studies	NULL
to	NULL
determine	NULL
the	NULL
contributions	NULL
of	NULL
the	NULL
promoter	NULL
,	NULL
enhancers	NULL
,	NULL
and	NULL
silencer	NULL
to	NULL
the	NULL
control	NULL
of	NULL
CD4	NULL
during	NULL
T-cell	NULL
development	NULL
.	NULL

ACKNOWLEDGMENTS	NULL
We	NULL
thank	NULL
Kathryn	NULL
Calame	NULL
,	NULL
Kong-Peng	NULL
Lam	NULL
,	NULL
and	NULL
Alan	NULL
Stall	NULL
for	NULL
helpful	NULL
comments	NULL
and	NULL
critical	NULL
review	NULL
of	NULL
the	NULL
manuscript	NULL
and	NULL
Jennifer	NULL
Haslam	NULL
for	NULL
technical	NULL
assistance	NULL
.	NULL

This	NULL
work	NULL
was	NULL
supported	NULL
by	NULL
grants	NULL
from	NULL
the	NULL
American	NULL
Cancer	NULL
Society	NULL
(	NULL
IM-739	NULL
,	NULL
JFRA-454	NULL
,	NULL
and	NULL
IRG-777	NULL
)	NULL
and	NULL
the	NULL
Council	NULL
for	NULL
Tobacco	NULL
Research	NULL
(	NULL
CTR3968	NULL
)	NULL
to	NULL
G.S	NULL
.	NULL

,	NULL
from	NULL
the	NULL
NCI	NULL
(	NULL
CA36246	NULL
)	NULL
and	NULL
ACS	NULL
(	NULL
0114	NULL
)	NULL
to	NULL
K.B.M	NULL
.	NULL

,	NULL
and	NULL
from	NULL
the	NULL
NIH	NULL
(	NULL
AI29990	NULL
)	NULL
to	NULL
S.M.H	NULL
.	NULL

REFERENCES	NULL
1	NULL
.	NULL

Ashfield	NULL
,	NULL
R.	NULL
,	NULL
A.	NULL
J.	NULL
Stupakoff	NULL
,	NULL
S.	NULL
A	NULL
.	NULL

B	NULL
,	NULL
H.	NULL
Brown	NULL
,	NULL
R.	NULL
D.	NULL
Campbell	NULL
,	NULL
K.	NULL
B.	NULL
Marcu	NULL
,	NULL
and	NULL
N.	NULL
J.	NULL
Proudfoot	NULL
.	NULL

1994	NULL
.	NULL

MAZ-dependent	NULL
termination	NULL
between	NULL
closely	NULL
spaced	NULL
human	NULL
complement	NULL
genes	NULL
.	NULL

EMBO	NULL
J	NULL
.	NULL

13:5656-5667	NULL
.	NULL

2	NULL
.	NULL

Asselin	NULL
,	NULL
C.	NULL
,	NULL
A.	NULL
Nepveu	NULL
,	NULL
and	NULL
K.	NULL
B.	NULL
Marcu	NULL
.	NULL

1989	NULL
.	NULL

Molecular	NULL
requirements	NULL
for	NULL
transcriptional	NULL
initiation	NULL
of	NULL
the	NULL
murine	NULL
c-myc	NULL
gene	NULL
.	NULL

Oncogene	NULL
4:549-558	NULL
.	NULL

3	NULL
.	NULL

Badiani	NULL
,	NULL
P.	NULL
,	NULL
P.	NULL
Corbella	NULL
,	NULL
D.	NULL
Kioussis	NULL
,	NULL
J.	NULL
Marvel	NULL
,	NULL
and	NULL
K.	NULL
Weston	NULL
.	NULL

1994	NULL
.	NULL

Dominant	NULL
interfering	NULL
alleles	NULL
define	NULL
a	NULL
role	NULL
for	NULL
c-Myb	NULL
in	NULL
T-cell	NULL
development	NULL
.	NULL

Genes	NULL
Dev	NULL
.	NULL

8:770-782	NULL
.	NULL

4	NULL
.	NULL

Blum	NULL
,	NULL
M.	NULL
D.	NULL
,	NULL
G.	NULL
T.	NULL
Wong	NULL
,	NULL
K.	NULL
M.	NULL
Higgins	NULL
,	NULL
M.	NULL
J.	NULL
Sunshine	NULL
,	NULL
and	NULL
E.	NULL
Lacy	NULL
.	NULL

1993	NULL
.	NULL

Reconstitution	NULL
of	NULL
the	NULL
subclass-specific	NULL
expression	NULL
of	NULL
CD4	NULL
in	NULL
thymocytes	NULL
and	NULL
peripheral	NULL
T	NULL
cells	NULL
of	NULL
transgenic	NULL
mice	NULL
:	NULL
identification	NULL
of	NULL
a	NULL
human	NULL
CD4	NULL
enhancer	NULL
.	NULL

J.	NULL
Exp	NULL
.	NULL

Med	NULL
.	NULL

177:1343-1358	NULL
.	NULL

5	NULL
.	NULL

Bossone	NULL
,	NULL
S.	NULL
A.	NULL
,	NULL
C.	NULL
Asselin	NULL
,	NULL
A.	NULL
J.	NULL
Patel	NULL
,	NULL
and	NULL
K.	NULL
B.	NULL
Marcu	NULL
.	NULL

1992	NULL
.	NULL

MAZ	NULL
,	NULL
a	NULL
zinc	NULL
finger	NULL
,	NULL
binds	NULL
to	NULL
a	NULL
c-myc	NULL
and	NULL
C2	NULL
gene	NULL
sequences	NULL
regulating	NULL
transcriptional	NULL
initiation	NULL
and	NULL
termination	NULL
.	NULL

Proc	NULL
.	NULL

Natl	NULL
.	NULL

Acad	NULL
.	NULL

Sci	NULL
.	NULL

USA	NULL
89:7452-7456	NULL
.	NULL

6	NULL
.	NULL

Chan	NULL
,	NULL
S.	NULL
H.	NULL
,	NULL
D.	NULL
Cosgrove	NULL
,	NULL
C.	NULL
Waltzinger	NULL
,	NULL
C.	NULL
Benoist	NULL
,	NULL
and	NULL
D.	NULL
Mathis	NULL
.	NULL

1993	NULL
.	NULL

Another	NULL
view	NULL
of	NULL
the	NULL
selective	NULL
model	NULL
of	NULL
thymocyte	NULL
selection	NULL
.	NULL

Cell	NULL
73:225-236	NULL
.	NULL

7	NULL
.	NULL

Davis	NULL
,	NULL
C.	NULL
B.	NULL
,	NULL
N.	NULL
Killeen	NULL
,	NULL
M.	NULL
E.	NULL
C.	NULL
Crooks	NULL
,	NULL
D.	NULL
Raulet	NULL
,	NULL
and	NULL
D.	NULL
R.	NULL
Littman	NULL
.	NULL

1993	NULL
.	NULL

Evidence	NULL
for	NULL
a	NULL
stochastic	NULL
mechanism	NULL
of	NULL
the	NULL
differentiation	NULL
of	NULL
mature	NULL
subsets	NULL
of	NULL
T	NULL
lymphocytes	NULL
.	NULL

Cell	NULL
73:237-247	NULL
.	NULL

8	NULL
.	NULL

De	NULL
Wet	NULL
,	NULL
J.	NULL
R.	NULL
,	NULL
K.	NULL
V.	NULL
Wood	NULL
,	NULL
M.	NULL
DeLuca	NULL
,	NULL
D.	NULL
R.	NULL
Helinski	NULL
,	NULL
and	NULL
S.	NULL
Subramani	NULL
.	NULL

A	NULL
MAZ	NULL
BINDING	NULL
SITE	NULL
IN	NULL
THE	NULL
CD4	NULL
PROMOTER	NULL
3185	NULL
1987	NULL
.	NULL

Firefly	NULL
luciferase	NULL
gene	NULL
:	NULL
structure	NULL
and	NULL
expression	NULL
in	NULL
mammalian	NULL
cells	NULL
.	NULL

Mol	NULL
.	NULL

Cell	NULL
.	NULL

Biol	NULL
.	NULL

7:725-737	NULL
.	NULL

9	NULL
.	NULL

Dufort	NULL
,	NULL
D.	NULL
,	NULL
and	NULL
A.	NULL
Nepveu	NULL
.	NULL

1994	NULL
.	NULL

The	NULL
human	NULL
Cut	NULL
homeodomain	NULL
protein	NULL
represses	NULL
transcription	NULL
from	NULL
the	NULL
e-myc	NULL
promoter	NULL
.	NULL

Mol	NULL
.	NULL

Cell	NULL
.	NULL

Biol	NULL
.	NULL

14:4251-4257	NULL
.	NULL

10	NULL
.	NULL

Fowlkes	NULL
,	NULL
B.	NULL
J.	NULL
,	NULL
and	NULL
D.	NULL
Pardoll	NULL
.	NULL

1989	NULL
.	NULL

Molecular	NULL
and	NULL
cellular	NULL
events	NULL
of	NULL
T	NULL
cell	NULL
development	NULL
.	NULL

Adv	NULL
.	NULL

Immunol	NULL
.	NULL

44:207-264	NULL
.	NULL

11	NULL
.	NULL

Germain	NULL
,	NULL
R.	NULL
N.	NULL
1994	NULL
.	NULL

MHC-dependent	NULL
antigen	NULL
processing	NULL
and	NULL
peptide	NULL
pre-sentation	NULL
:	NULL
providing	NULL
ligands	NULL
for	NULL
T	NULL
lymphocyte	NULL
activation	NULL
.	NULL

Cell	NULL
76:287-299	NULL
.	NULL

12	NULL
.	NULL

Ghosh	NULL
,	NULL
D.	NULL
1992	NULL
.	NULL

TFD	NULL
:	NULL
the	NULL
transcription	NULL
factors	NULL
database	NULL
.	NULL

Nucleic	NULL
Acids	NULL
Res	NULL
.	NULL

20:2091-2093	NULL
.	NULL

13	NULL
.	NULL

Gillespie	NULL
,	NULL
F.	NULL
P.	NULL
,	NULL
L.	NULL
Doros	NULL
,	NULL
J.	NULL
Vitale	NULL
,	NULL
C.	NULL
Blackwell	NULL
,	NULL
J.	NULL
Gosselin	NULL
,	NULL
B.	NULL
W.	NULL
Snyder	NULL
,	NULL
and	NULL
S.	NULL
C.	NULL
Wadsworth	NULL
.	NULL

1993	NULL
.	NULL

Tissue-specific	NULL
expression	NULL
of	NULL
human	NULL
CD4	NULL
in	NULL
transgenic	NULL
mice	NULL
.	NULL

Mol	NULL
.	NULL

Cell	NULL
.	NULL

Biol	NULL
.	NULL

13:2952-2958	NULL
.	NULL

14	NULL
.	NULL

Hanna	NULL
,	NULL
Z.	NULL
,	NULL
C.	NULL
Simard	NULL
,	NULL
A.	NULL
LaPerriere	NULL
,	NULL
and	NULL
P.	NULL
Jolicoeur	NULL
.	NULL

1994	NULL
.	NULL

Specific	NULL
expression	NULL
of	NULL
the	NULL
human	NULL
CD4	NULL
gene	NULL
in	NULL
mature	NULL
CD4*	NULL
CD8~	NULL
and	NULL
immature	NULL
CD4*	NULL
CD8	NULL
*	NULL
T	NULL
cells	NULL
and	NULL
in	NULL
macrophages	NULL
of	NULL
transgenic	NULL
mice	NULL
.	NULL

Mol	NULL
.	NULL

Cell	NULL
.	NULL

Biol	NULL
.	NULL

14:1084-1094	NULL
.	NULL

15	NULL
.	NULL

Javahery	NULL
,	NULL
R.	NULL
,	NULL
A.	NULL
Khachi	NULL
,	NULL
K.	NULL
Lo	NULL
,	NULL
B.	NULL
Zenzie-Gregory	NULL
,	NULL
and	NULL
S.	NULL
T.	NULL
Smale	NULL
.	NULL

1994	NULL
.	NULL

DNA	NULL
sequence	NULL
requirements	NULL
for	NULL
transcriptional	NULL
initiator	NULL
activity	NULL
in	NULL
mammalian	NULL
cells	NULL
.	NULL

Mol	NULL
.	NULL

Cell	NULL
.	NULL

Biol	NULL
.	NULL

14:116-127	NULL
.	NULL

16	NULL
.	NULL

Jones	NULL
,	NULL
N.	NULL
C.	NULL
,	NULL
P.	NULL
W.	NULL
Rigby	NULL
,	NULL
and	NULL
E.	NULL
B.	NULL
Ziff	NULL
.	NULL

1988	NULL
.	NULL

Trans-acting	NULL
protein	NULL
factors	NULL
and	NULL
the	NULL
regulation	NULL
of	NULL
eukaryotic	NULL
transcription	NULL
:	NULL
lessons	NULL
from	NULL
studies	NULL
on	NULL
DNA	NULL
tumor	NULL
viruses	NULL
.	NULL

Genes	NULL
Dev	NULL
.	NULL

2:267-281	NULL
.	NULL

17	NULL
.	NULL

Kadonaga	NULL
,	NULL
J.	NULL
T.	NULL
,	NULL
K.	NULL
A.	NULL
Jones	NULL
,	NULL
and	NULL
R.	NULL
Tjian	NULL
.	NULL

1986	NULL
.	NULL

Promoter-specific	NULL
activation	NULL
of	NULL
RNA	NULL
polymerase	NULL
II	NULL
transcription	NULL
by	NULL
Sp1	NULL
.	NULL

Trends	NULL
Biol	NULL
.	NULL

Sci	NULL
.	NULL

11:20-23	NULL
.	NULL

18	NULL
.	NULL

Kennedy	NULL
,	NULL
G.	NULL
C.	NULL
,	NULL
and	NULL
W.	NULL
J.	NULL
Rutter	NULL
.	NULL

1992	NULL
.	NULL

Pur-1	NULL
,	NULL
a	NULL
zinc-finger	NULL
protein	NULL
that	NULL
binds	NULL
to	NULL
purine-rich	NULL
sequences	NULL
,	NULL
transactivates	NULL
an	NULL
insulin	NULL
promoter	NULL
in	NULL
heterologous	NULL
cells	NULL
.	NULL

Proc	NULL
.	NULL

Natl	NULL
.	NULL

Acad	NULL
.	NULL

Sci	NULL
.	NULL

USA	NULL
89:11498-11502	NULL
.	NULL

19	NULL
.	NULL

Killeen	NULL
,	NULL
N.	NULL
,	NULL
S.	NULL
Sawada	NULL
,	NULL
and	NULL
D.	NULL
R.	NULL
Littman	NULL
.	NULL

1993	NULL
.	NULL

Regulated	NULL
expression	NULL
of	NULL
human	NULL
CD4	NULL
rescues	NULL
helper	NULL
T	NULL
cell	NULL
development	NULL
in	NULL
mice	NULL
lacking	NULL
expression	NULL
of	NULL
endogenous	NULL
CD4	NULL
.	NULL

EMBO	NULL
J	NULL
.	NULL

12:1547-1553	NULL
.	NULL

20	NULL
.	NULL

Kunkel	NULL
,	NULL
T.	NULL
A.	NULL
,	NULL
J.	NULL
D.	NULL
Roberts	NULL
,	NULL
and	NULL
R.	NULL
A.	NULL
Zakour	NULL
.	NULL

1987	NULL
.	NULL

Rapid	NULL
and	NULL
efficient	NULL
site-specific	NULL
mutagenesis	NULL
without	NULL
phenotypic	NULL
selection	NULL
.	NULL

Methods	NULL
Enzymol	NULL
.	NULL

154:367-382	NULL
.	NULL

21	NULL
.	NULL

Littman	NULL
,	NULL
D.	NULL
R.	NULL
1987	NULL
.	NULL

The	NULL
structure	NULL
of	NULL
the	NULL
CD4	NULL
and	NULL
CD8	NULL
genes	NULL
.	NULL

Annu	NULL
.	NULL

Rev	NULL
.	NULL

Immunol	NULL
.	NULL

5:561-584	NULL
.	NULL

22	NULL
.	NULL

Miller	NULL
,	NULL
H.	NULL
,	NULL
C.	NULL
Asselin	NULL
,	NULL
D.	NULL
Dufort	NULL
,	NULL
J.	NULL
Yang	NULL
,	NULL
K.	NULL
Gupta	NULL
,	NULL
K.	NULL
B.	NULL
Marcu	NULL
,	NULL
and	NULL
A.	NULL
Nepveu	NULL
.	NULL

1989	NULL
.	NULL

A	NULL
cis-acting	NULL
clement	NULL
in	NULL
the	NULL
promoter	NULL
region	NULL
of	NULL
the	NULL
murine	NULL
c-myc	NULL
gene	NULL
is	NULL
necessary	NULL
for	NULL
transcriptional	NULL
block	NULL
.	NULL

Mol	NULL
.	NULL

Cell	NULL
.	NULL

Biol	NULL
.	NULL

9:5340-5349	NULL
.	NULL

23	NULL
.	NULL

Natesan	NULL
,	NULL
S.	NULL
,	NULL
and	NULL
M.	NULL
Z.	NULL
Gilman	NULL
.	NULL

1993	NULL
.	NULL

DNA	NULL
bending	NULL
and	NULL
orientation-depen-dent	NULL
function	NULL
of	NULL
YY1	NULL
in	NULL
the	NULL
c-fos	NULL
promoter	NULL
.	NULL

Genes	NULL
Dev	NULL
.	NULL

7:2497-2509	NULL
.	NULL

24	NULL
.	NULL

Nossal	NULL
,	NULL
G.	NULL
J.	NULL
V.	NULL
1994	NULL
.	NULL

Negative	NULL
selection	NULL
of	NULL
lymphocytes	NULL
.	NULL

Cell	NULL
76:229-239	NULL
.	NULL

25	NULL
.	NULL

Paillard	NULL
,	NULL
F.	NULL
,	NULL
G.	NULL
Sterkers	NULL
,	NULL
and	NULL
C.	NULL
Vaquero	NULL
.	NULL

1990	NULL
.	NULL

Transcriptional	NULL
and	NULL
post-transcriptional	NULL
regulation	NULL
of	NULL
TeR	NULL
,	NULL
CD4	NULL
,	NULL
and	NULL
CD8	NULL
gene	NULL
expression	NULL
during	NULL
activation	NULL
of	NULL
normal	NULL
human	NULL
T	NULL
lymphocytes	NULL
.	NULL

EMBO	NULL
J	NULL
.	NULL

9:1867-1872	NULL
.	NULL

26	NULL
.	NULL

Parnes	NULL
,	NULL
J.	NULL
R.	NULL
1989	NULL
.	NULL

Molecular	NULL
biology	NULL
and	NULL
function	NULL
of	NULL
CD4	NULL
and	NULL
CD8	NULL
.	NULL

Adv	NULL
.	NULL

Immunol	NULL
44:265-311	NULL
.	NULL

26a.Patel	NULL
,	NULL
A.	NULL
,	NULL
and	NULL
K.	NULL
B.	NULL
Marcu	NULL
.	NULL

Unpublished	NULL
data	NULL
.	NULL

27	NULL
.	NULL

Pugh	NULL
,	NULL
B.	NULL
F.	NULL
,	NULL
and	NULL
R.	NULL
Tjian	NULL
.	NULL

1991	NULL
.	NULL

Transcription	NULL
from	NULL
a	NULL
TATA-less	NULL
promoter	NULL
requires	NULL
a	NULL
multisubunit	NULL
TFIID	NULL
complex	NULL
.	NULL

Genes	NULL
Dev	NULL
.	NULL

5:1935-1945	NULL
.	NULL

28	NULL
.	NULL

Pyrc	NULL
,	NULL
J.	NULL
J.	NULL
,	NULL
K.	NULL
H.	NULL
Moberg	NULL
,	NULL
and	NULL
D.	NULL
J	NULL
.	NULL

Hall	NULL
.	NULL

1992	NULL
.	NULL

Isolation	NULL
of	NULL
a	NULL
novel	NULL
cDNA	NULL
encoding	NULL
a	NULL
zinc-finger	NULL
protein	NULL
that	NULL
binds	NULL
to	NULL
two	NULL
sites	NULL
within	NULL
the	NULL
c-myc	NULL
promoter	NULL
.	NULL

Biochemistry	NULL
31:4102-4110	NULL
.	NULL

29	NULL
.	NULL

Robey	NULL
,	NULL
E.	NULL
A.	NULL
,	NULL
B.	NULL
J.	NULL
Fowlkes	NULL
,	NULL
J.	NULL
W.	NULL
Gordon	NULL
,	NULL
D.	NULL
Kioussis	NULL
,	NULL
H.	NULL
von	NULL
Boehmer	NULL
,	NULL
F.	NULL
Ramsdell	NULL
,	NULL
and	NULL
R.	NULL
Axel	NULL
.	NULL

1991	NULL
.	NULL

Thymic	NULL
selection	NULL
in	NULL
CD8	NULL
transgenic	NULL
mice	NULL
supports	NULL
an	NULL
instructive	NULL
model	NULL
for	NULL
commitment	NULL
to	NULL
a	NULL
CD4	NULL
or	NULL
CD8	NULL
lineage	NULL
.	NULL

Cell	NULL
64:99-107	NULL
.	NULL

30	NULL
.	NULL

Salmon	NULL
,	NULL
P.	NULL
,	NULL
A.	NULL
Giovane	NULL
,	NULL
B.	NULL
Wasylyk	NULL
,	NULL
and	NULL
D.	NULL
Klatzmann	NULL
.	NULL

1993	NULL
.	NULL

Characterization	NULL
of	NULL
the	NULL
human	NULL
CD4	NULL
gene	NULL
promoter	NULL
:	NULL
transcription	NULL
from	NULL
the	NULL
CD4	NULL
gene	NULL
core	NULL
promoter	NULL
is	NULL
tissue-specific	NULL
and	NULL
is	NULL
activated	NULL
by	NULL
Ets	NULL
proteins	NULL
.	NULL

Proc	NULL
.	NULL

Natl	NULL
.	NULL

Acad	NULL
.	NULL

Sci	NULL
.	NULL

USA	NULL
90:7739-7743	NULL
.	NULL

31	NULL
.	NULL

Sawada	NULL
,	NULL
S.	NULL
,	NULL
and	NULL
D.	NULL
R.	NULL
Littman	NULL
.	NULL

1991	NULL
.	NULL

Identification	NULL
and	NULL
characterization	NULL
of	NULL
a	NULL
T-cell-specific	NULL
enhancer	NULL
adjacent	NULL
to	NULL
the	NULL
murine	NULL
CD4	NULL
gene	NULL
.	NULL

Mol	NULL
.	NULL

Cell	NULL
.	NULL

Biol	NULL
.	NULL

11:5506-5515	NULL
.	NULL

32	NULL
.	NULL

Sawada	NULL
,	NULL
S.	NULL
,	NULL
and	NULL
D.	NULL
R.	NULL
Littman	NULL
.	NULL

1993	NULL
.	NULL

A	NULL
heterodimer	NULL
of	NULL
HEB	NULL
and	NULL
an	NULL
E12-related	NULL
protein	NULL
interacts	NULL
with	NULL
the	NULL
CD4	NULL
enhancer	NULL
and	NULL
regulates	NULL
its	NULL
activity	NULL
in	NULL
T-cell	NULL
lines	NULL
.	NULL

Mol	NULL
.	NULL

Cell	NULL
.	NULL

Biol	NULL
.	NULL

13:5620-5628	NULL
.	NULL

33	NULL
.	NULL

Sawada	NULL
,	NULL
S.	NULL
,	NULL
J.	NULL
D.	NULL
Scarborough	NULL
,	NULL
N.	NULL
Killeen	NULL
,	NULL
and	NULL
D.	NULL
R.	NULL
Littman	NULL
.	NULL

1994	NULL
.	NULL

A	NULL
lineage-specific	NULL
transcriptional	NULL
silencer	NULL
regulates	NULL
CD4	NULL
gene	NULL
expression	NULL
during	NULL
T	NULL
lymphocyte	NULL
development	NULL
.	NULL

Cell	NULL
77:917-929	NULL
.	NULL

34	NULL
.	NULL

Siu	NULL
,	NULL
G.	NULL
,	NULL
S.	NULL
M.	NULL
Hedrick	NULL
,	NULL
M.	NULL
L.	NULL
Waterman	NULL
,	NULL
and	NULL
K.	NULL
A.	NULL
Jones	NULL
.	NULL

Unpublished	NULL
data	NULL
.	NULL

35	NULL
.	NULL

Siu	NULL
,	NULL
G.	NULL
,	NULL
A.	NULL
L.	NULL
Wurster	NULL
,	NULL
D.	NULL
D.	NULL
Duncan	NULL
,	NULL
T.	NULL
M.	NULL
Soliman	NULL
,	NULL
and	NULL
S.	NULL
M.	NULL
Hedrick	NULL
.	NULL

1994	NULL
.	NULL

A	NULL
transcriptional	NULL
silencer	NULL
controls	NULL
the	NULL
developmental	NULL
expression	NULL
of	NULL
the	NULL
CD4	NULL
gene	NULL
.	NULL

EMBO	NULL
J	NULL
.	NULL

13:3570-3579	NULL
.	NULL

36	NULL
.	NULL

Siu	NULL
,	NULL
G.	NULL
,	NULL
A.	NULL
L.	NULL
Wurster	NULL
,	NULL
J.	NULL
S.	NULL
Lipsick	NULL
,	NULL
and	NULL
S.	NULL
M.	NULL
Hedrick	NULL
.	NULL

1992	NULL
.	NULL

Expression	NULL
of	NULL
the	NULL
CD4	NULL
gene	NULL
requires	NULL
a	NULL
Myb	NULL
transcription	NULL
factor	NULL
.	NULL

Mol	NULL
.	NULL

Cell	NULL
.	NULL

Biol	NULL
.	NULL

12:1592-1604	NULL
.	NULL

37	NULL
.	NULL

Stupakoff	NULL
,	NULL
A.	NULL
,	NULL
S.	NULL
Bossone	NULL
,	NULL
and	NULL
K.	NULL
B.	NULL
Marcu	NULL
.	NULL

Unpublished	NULL
data	NULL
.	NULL

38	NULL
.	NULL

Swain	NULL
,	NULL
S.	NULL
1983	NULL
.	NULL

T	NULL
cell	NULL
subsets	NULL
and	NULL
the	NULL
recognition	NULL
of	NULL
MHC	NULL
class	NULL
.	NULL

Immunol	NULL
.	NULL

Rev	NULL
.	NULL

74:129-142	NULL
.	NULL

3186	NULL
39	NULL
.	NULL

40	NULL
.	NULL

41	NULL
.	NULL

42	NULL
.	NULL

43	NULL
.	NULL

44	NULL
.	NULL

45	NULL
.	NULL

DUNCAN	NULL
ET	NULL
AL	NULL
.	NULL

Takahama	NULL
,	NULL
V.	NULL
,	NULL
and	NULL
A	NULL
.	NULL

Singer	NULL
.	NULL

1992	NULL
.	NULL

Post-transcriptional	NULL
regulation	NULL
of	NULL
carly	NULL
T	NULL
cell	NULL
development	NULL
by	NULL
T	NULL
cell	NULL
receptor	NULL
signals	NULL
.	NULL

Science	NULL
258:1456-1462	NULL
.	NULL

Thanos	NULL
,	NULL
D.	NULL
,	NULL
and	NULL
T.	NULL
Maniatis	NULL
.	NULL

1992	NULL
.	NULL

The	NULL
high	NULL
mobility	NULL
group	NULL
protein	NULL
HMG	NULL
I	NULL
(	NULL
Y	NULL
)	NULL
is	NULL
required	NULL
for	NULL
NF-	NULL
Â«	NULL
B	NULL
dependent	NULL
virus	NULL
induction	NULL
of	NULL
the	NULL
human	NULL
IFN-B	NULL
gene	NULL
.	NULL

Cell	NULL
71:777-789	NULL
.	NULL

Travis	NULL
,	NULL
A.	NULL
,	NULL
A.	NULL
Amsterdam	NULL
,	NULL
C.	NULL
Belanger	NULL
,	NULL
and	NULL
R.	NULL
Grosschedl	NULL
.	NULL

1991	NULL
.	NULL

LEF-1	NULL
,	NULL
a	NULL
gene	NULL
encoding	NULL
a	NULL
lymphoid-specific	NULL
protein	NULL
with	NULL
an	NULL
HMG	NULL
domain	NULL
,	NULL
regulates	NULL
T-cell	NULL
receptor	NULL
alpha	NULL
enhancer	NULL
function	NULL
.	NULL

Genes	NULL
Dev	NULL
.	NULL

5:880-894.	NULL
von	NULL
Boehmer	NULL
,	NULL
H.	NULL
1988	NULL
.	NULL

The	NULL
developmental	NULL
biology	NULL
of	NULL
T	NULL
lymphocytes	NULL
.	NULL

Annu	NULL
.	NULL

Rev	NULL
.	NULL

Immunol	NULL
.	NULL

6309-326.	NULL
von	NULL
Boehmer	NULL
,	NULL
H.	NULL
1994	NULL
.	NULL

Positive	NULL
selection	NULL
of	NULL
lymphocytes	NULL
.	NULL

Cell	NULL
76:219-228.	NULL
von	NULL
Boehmer	NULL
,	NULL
H.	NULL
,	NULL
and	NULL
P.	NULL
Kisielow	NULL
.	NULL

1993	NULL
.	NULL

Lymphocyte	NULL
lincage	NULL
commitment	NULL
:	NULL
instruction	NULL
versus	NULL
selection	NULL
.	NULL

Cell	NULL
73:207-208	NULL
.	NULL

Waterman	NULL
,	NULL
M.	NULL
L.	NULL
,	NULL
W.	NULL
H.	NULL
Fischer	NULL
,	NULL
and	NULL
K.	NULL
A.	NULL
Jones	NULL
.	NULL

1991	NULL
.	NULL

A	NULL
thymus-specific	NULL
46	NULL
.	NULL

47	NULL
.	NULL

48	NULL
.	NULL

49	NULL
.	NULL

Mor	NULL
.	NULL

CELL	NULL
.	NULL

BioL	NULL
.	NULL

member	NULL
of	NULL
the	NULL
HMG	NULL
protein	NULL
family	NULL
regulates	NULL
the	NULL
human	NULL
T	NULL
cell	NULL
receptor	NULL
Ca	NULL
enhancer	NULL
.	NULL

Genes	NULL
Dev	NULL
.	NULL

5:656-669	NULL
.	NULL

Waterman	NULL
,	NULL
M.	NULL
L.	NULL
,	NULL
and	NULL
K.	NULL
A.	NULL
Jones	NULL
.	NULL

1990	NULL
.	NULL

Purification	NULL
of	NULL
TCF-1	NULL
Â«	NULL
,	NULL
a	NULL
T-cell-specific	NULL
transcription	NULL
factor	NULL
that	NULL
activates	NULL
the	NULL
T-cell	NULL
receptor	NULL
Ca	NULL
gene	NULL
enhancer	NULL
in	NULL
a	NULL
context-dependent	NULL
manner	NULL
.	NULL

New	NULL
Biol	NULL
.	NULL

2:621-636	NULL
.	NULL

Wright	NULL
,	NULL
S.	NULL
,	NULL
and	NULL
J.	NULL
M.	NULL
Bishop	NULL
.	NULL

1989	NULL
.	NULL

DNA	NULL
sequence	NULL
that	NULL
mediates	NULL
attenuation	NULL
of	NULL
transcription	NULL
from	NULL
the	NULL
mouse	NULL
protooncogene	NULL
myc	NULL
.	NULL

Proc	NULL
.	NULL

Natl	NULL
.	NULL

Acad	NULL
.	NULL

Sci	NULL
.	NULL

USA	NULL
86:505-509	NULL
.	NULL

Wu	NULL
,	NULL
L.	NULL
,	NULL
R.	NULL
Scollay	NULL
,	NULL
M.	NULL
Egerton	NULL
,	NULL
M.	NULL
Pearse	NULL
,	NULL
G.	NULL
J.	NULL
Spangrude	NULL
,	NULL
and	NULL
K.	NULL
Short-man	NULL
.	NULL

1991	NULL
.	NULL

CD4	NULL
expressed	NULL
on	NULL
earliest	NULL
T-lineage	NULL
precursor	NULL
cells	NULL
in	NULL
the	NULL
adult	NULL
murine	NULL
thymus	NULL
.	NULL

Nature	NULL
(	NULL
London	NULL
)	NULL
349:71-74	NULL
.	NULL

Wurster	NULL
,	NULL
A.	NULL
L.	NULL
,	NULL
G.	NULL
Siu	NULL
,	NULL
J.	NULL
Leiden	NULL
,	NULL
and	NULL
S.	NULL
M.	NULL
Hedrick	NULL
.	NULL

1994	NULL
.	NULL

Elf-1	NULL
binds	NULL
to	NULL
a	NULL
critical	NULL
element	NULL
in	NULL
a	NULL
second	NULL
CD4	NULL
enhancer	NULL
.	NULL

Mol	NULL
.	NULL

Cell	NULL
.	NULL

Biol	NULL
.	NULL

14:6452-6463	NULL
.	NULL

